UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐ Preliminary Proxy Statement |
||
☐ Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||
☒ Definitive Proxy Statement |
||
☐ Definitive Additional Materials | ||
☐ Soliciting Material Under Rule 14a-12 |
Philip Morris International Inc.
(Name of Registrant as Specified in Its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ | No fee required. |
☐ | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
(1) | Title of each class of securities to which transaction applies: |
(2) | Aggregate number of securities to which transaction applies: |
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
(4) | Proposed maximum aggregate value of transaction: |
(5) | Total fee paid: |
☐ | Fee paid previously with preliminary materials: |
☐ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the form or schedule and the date of its filing. |
(1) | Amount previously paid: |
(2) | Form, Schedule or Registration Statement No.: |
(3) | Filing Party: |
(4) | Date Filed: March 23, 2017 |
2017 PROXY STATEMENT
And Notice of Annual Meeting of Shareholders
To be held on Wednesday, May 3, 2017
[THIS PAGE INTENTIONALLY LEFT BLANK]
March 23, 2017
Dear Fellow Shareholder,
You are cordially invited to join us at the 2017 Annual Meeting of Shareholders of Philip Morris International Inc. (PMI or the Company) to be held on Wednesday, May 3, 2017, at 9:00 a.m., in the Empire State Ballroom at the Grand Hyatt New York, 109 East 42nd Street, New York, New York.
At this years meeting, we will vote on the election of thirteen directors, an advisory say-on-pay vote approving executive compensation, an advisory resolution regarding the frequency of future say-on-pay votes, the approval of the 2017 Performance Incentive Plan, the approval of the 2017 Stock Compensation Plan for Non-Employee Directors, the ratification of the selection of PricewaterhouseCoopers SA as the Companys independent auditors, and, if properly presented, two proposals from shareholders. There will also be a report on the Companys business, and shareholders will have an opportunity to ask questions.
We anticipate that a large number of shareholders will attend the meeting. Because seating is limited, you may bring only one immediate family member as a guest. All attendees must present an admission ticket and government-issued photographic identification. To request an admission ticket, please follow the instructions set forth on page 75 in response to Question 4.
The meeting facilities will open at 7:30 a.m. on May 3, 2017. We suggest you arrive early to facilitate your registration and security clearance. Those needing special assistance at the meeting are requested to write to the Companys Corporate Secretary at 120 Park Avenue, New York, New York 10017-5579. For your comfort and security, you will not be permitted to bring any packages, briefcases, large pocketbooks or bags into the meeting. Also, cellular and digital phones, audio tape recorders, laptops and other portable electronic devices, video and still cameras, pagers and pets will not be permitted into the meeting. We thank you in advance for your patience and cooperation with these rules, which assist us in conducting a safe and orderly meeting.
Attached you will find a notice of meeting and proxy statement that contains additional information about the meeting, including the methods that you can use to vote your proxy, such as the telephone or Internet. As we did last year, we are mailing to certain of our shareholders a Notice of Internet Availability of Proxy Materials. This Notice contains instructions on how to access our proxy statement and 2016 Annual Report to Shareholders and vote online. Those shareholders who do not receive the Notice will receive a paper copy of the proxy materials by mail. By furnishing this Notice, we are lowering costs and reducing the environmental impact of our Annual Meeting.
Your vote is important. We encourage you to sign and return your proxy card, or use telephone or Internet voting prior to the meeting, so that your shares of common stock will be represented and voted at the meeting even if you cannot attend.
Sincerely, |
Sincerely, | |
|
| |
LOUIS C. CAMILLERI CHAIRMAN OF THE BOARD |
ANDRÉ CALANTZOPOULOS CHIEF EXECUTIVE OFFICER |
For further information about the Annual Meeting, please call toll-free 1-866-713-8075.
PMI 2017 Proxy Statement 1
PHILIP MORRIS INTERNATIONAL INC. |
NOTICE OF 2017 ANNUAL MEETING OF SHAREHOLDERS
Date and Time | 9:00 a.m. on Wednesday, May 3, 2017 | |
Place | Empire State Ballroom Grand Hyatt New York 109 East 42nd Street New York, New York | |
Items of Business | (1) To elect thirteen directors. | |
(2) To vote on an advisory resolution approving executive compensation. | ||
(3) To vote on an advisory resolution on the frequency of future advisory votes on executive compensation. | ||
(4) To approve the 2017 Performance Incentive Plan. | ||
(5) To approve the 2017 Stock Compensation Plan for Non-Employee Directors. | ||
(6) To ratify the selection of PricewaterhouseCoopers SA as independent auditors for the Company for the fiscal year ending December 31, 2017. | ||
(7) To vote on two shareholder proposals, if properly presented at the meeting. | ||
(8) To transact other business properly coming before the meeting. | ||
Who Can Vote | Only shareholders of record of shares of common stock at the close of business on March 10, 2017 (the Record Date) are entitled to notice of and to vote at the meeting, or at any adjournments or postponements of the meeting. Each shareholder of record on the Record Date is entitled to one vote for each share of common stock held. On March 10, 2017, there were 1,553,138,929 shares of common stock issued and outstanding. | |
Voting of Proxies and Deadline for Receipt |
All properly executed written proxies, and all properly completed proxies submitted by telephone or Internet, that are delivered pursuant to this solicitation will be voted at the meeting in accordance with the directions given in the proxy, unless the proxy is revoked before the meeting. Proxies submitted by telephone or Internet must be received by 11:59 p.m., EDT, on May 2, 2017. | |
2016 Annual Report | A copy of our 2016 Annual Report is enclosed. | |
Date of Mailing | This notice and the proxy statement are first being mailed to shareholders on or about March 23, 2017. |
Jerry Whitson
Deputy General Counsel and Corporate Secretary
March 23, 2017
WE URGE EACH SHAREHOLDER TO PROMPTLY SIGN AND RETURN THE ENCLOSED PROXY CARD OR TO USE TELEPHONE OR INTERNET VOTING. SEE THE QUESTION AND ANSWER SECTION FOR INFORMATION ABOUT VOTING BY TELEPHONE OR INTERNET, HOW TO REVOKE A PROXY, AND HOW TO VOTE YOUR SHARES OF COMMON STOCK IN PERSON. PLEASE NOTE THAT YOU MUST OBTAIN AN ADMISSION TICKET IN ORDER TO ATTEND THE MEETING. TO OBTAIN AN ADMISSION TICKET, PLEASE FOLLOW THE INSTRUCTIONS SET FORTH ON PAGE 75 IN RESPONSE TO QUESTION 4.
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting of Shareholders to be held on May 3, 2017: The Companys Proxy Statement and 2016 Annual Report are available at
www.pmi.com/investors.
2 PMI 2017 Proxy Statement
LETTER FROM THE BOARD OF DIRECTORS |
Dear Fellow Shareholder,
Last year, with the full support of the Board of Directors, your Company announced that its key strategic priority is to develop and commercialize smoke-free products that are a much better choice than cigarette smoking, and to lead a full-scale effort to ensure that smoke-free products replace cigarettes to the benefit of adult smokers, society, our Company and its shareholders. As your Company engages in the tremendous external and internal transformation necessary to achieving that goal, the Board wishes to take this opportunity to discuss how it perceives and performs its corporate governance role and oversees managements efforts to enhance shareholder value responsibly and sustainably over the long term.
Over the last decade, the Board has spent an increasing portion of its time overseeing the Companys RRP progress. We engage actively in several aspects of this effort. We discuss with the Companys scientists and engineers their progress in designing multiple Reduced-Risk Product platforms, and in conducting rigorous scientific assessments of these platforms. We monitor the Companys progress in preparing regulatory submissions for these products. Since the spin-off in 2008, we have considered and approved more than $3 billion in expenditures to research and develop these products and to manufacture them. We closely follow the Companys steps to commercialize the IQOS product, as well as other RRP platforms. Recognizing that these products are not risk free, we monitor managements engagement with regulators as it seeks to ensure that RRPs are responsibly developed, scientifically assessed and marketed. The Board oversees managements efforts to assure that the Companys employees are prepared and equipped to meet the new and substantial challenges of the Companys transformation from cigarettes to RRPs. The Board is also overseeing managements development of key performance indicators, or KPIs, so that the Company can track and publicly report its transformation progress. To learn more about the Companys RRP program, please visit www.pmiscience.com.
As exemplified by the significant investments of money, time and organizational effort in RRPs, the core of the Boards oversight framework is a focus on long-term versus short-term results. The Board devotes two meeting days each year to reviewing, understanding, discussing and challenging managements long-range strategic plan. It also approves the original budget each year, and its Compensation and Leadership Development Committee sets performance goals based on that budget that determine incentive compensation levels for the Companys management team. We receive updates on the Companys progress against the budget and the long-range plan throughout the year.
The Board believes that operating with integrity and in full compliance with law and regulation are central to the Companys business strategy. Company leaders must unequivocally evince this principle with an unmistakable and unwavering tone-at-the-top. In the words of our Chairman, the essence of effective compliance is candor, transparency and honesty. To reinforce this message throughout the organization, each year the Board meets in one of our key markets, most recently in Russia, Japan, Italy, Germany, Mexico and Turkey, and the Audit Committee meets with the local finance department in another key market.
Another critical role of the Board is to oversee that the Company effectively identifies, owns, manages and mitigates enterprise risks. In the past two years, management has structured a more formal process to deal with enterprise risks, as discussed on page 14 of this proxy statement. Management reports to the Board and its Committees with respect to these risks throughout the year.
The Board understands the Companys special responsibility as a tobacco company. In addition to RRPs, the Board oversees the Companys progress to improve continuously the sustainability of the Companys business and its value chain and to contribute to the global sustainability agenda. In 2015, with the Boards encouragement, the Company became the only international tobacco company to date to join the United Nations Global Compact, an initiative to encourage businesses worldwide to adopt sustainable and socially responsible policies, and to report on their implementation. The Company filed its first Communication on Progress last year, detailing our progress vis-à-vis the Compacts Ten Principles in the areas of human rights, labor, environment and anti-corruption. The cornerstone of the report to the U.N. is the Companys determination to address the health impact of combustible tobacco products through RRPs. Space prevents our summarizing this important report here, but it can be found at www.pmi.com/sustainability, and we commend it to you.
In 2016, the Company also published its third report on its Agricultural Labor Practices program; the report describes the scope of the program and the Companys commitment to and progress in implementing good agricultural practices that
PMI 2017 Proxy Statement 3
LETTER FROM THE BOARD OF DIRECTORS |
support farmers in improving the quality and productivity of their crops, improving food security and diversification, respecting the environment, and achieving safe and fair labor practices. The program, which is independently monitored and audited and reported transparently, has earned praise from several sources, including the United States Department of Labor and Human Rights Watch. Our 2014-2015 Progress Report can be found at www.pmi.com/sustainability.
We encourage the Companys efforts regarding the environment, which resulted in its being awarded Climate A List status in the CDP Global Climate Leaders Report for the third year in a row and placing the Company in the top 5% of more than 2,200 of the worlds largest companies that were assessed on their carbon footprint.
We commend the Companys efforts to advance the socio-economic well-being of the communities in which it has a presence. Last year the Company partnered with more than 200 not-for-profit organizations to support 236 projects in 55 countries, focused on improving access to education, empowering women, and promoting economic opportunities to benefit the most vulnerable populations, while also providing emergency relief to communities suffering natural disasters in the Dominican Republic, Ecuador, Ethiopia, Indonesia, Italy, Japan, Malawi, Mozambique, the Philippines, and Portugal.
The Board also encourages management to continue to educate, train, develop and manage the Companys talented workforce. As a testament to managements commitment to offering an enriching work environment and exceptional development opportunities, and initiatives such as adopting flexible work arrangements to help employees balance their working and private lives, the Top Employer Institute recently certified the Company as a Global Top Employer in 34 countries. The Board reviews the Companys progress in improving diversity and inclusion against key performance indicators, including its goals of achieving a new hire ratio of 50% female by the end of this year and increasing the proportion of females in management positions to 40% by 2022. We also monitor the Companys pay scales and promotion rates for females and are pleased that it has earned equal salary certifications in Japan and Switzerland and was recognized in the Profiles in Diversity Journal as one of ten companies for innovation excellence in diversity and inclusion.
Through the Companys Compensation and Leadership Development Committee, the Board strives to link pay to performance, not just for financial results, but also with respect to the Companys strategic objectives to develop and commercialize RRPs, to improve sustainability, to manage talent, to increase diversity and inclusion, and to maintain robust central compliance and integrity programs. The Companys progress in achieving each of those strategic objectives is built into the equation that determines the level of incentive awards earned by the Companys executives. The Committee and the full Board also review and assist in the development of executive succession plans.
Page 10 of the proxy statement discusses the Boards leadership structure, while page 17 outlines the attributes the Board seeks in its members, the Boards diversity and global perspective, its healthy pace of director refreshment, and its relatively short average tenure.
Page 8 of this proxy statement discusses the Companys extensive investor outreach program, the results of which are reported to the Board and the appropriate committees, and the Boards recent actions taken to reflect investor input in the areas of compensation structure and governance practices. A summary of the governance practices established by the Board can be found on page 16.
The Board believes the various corporate governance practices are tools, not outcomes for achievement in and of themselves. Ultimately, the question is not whether a particular governance box is checked, but whether a company acts responsibly in a manner aligned with the expectations of its consumers, its shareholders and society. The Board is confident that your Company meets, and will continue to meet, that critical standard.
The Boards relationship with management is excellent. Managements communications are thorough and transparent. Management forthrightly informs the Board of all relevant matters, whether good or bad. It responds readily to all of the Boards requests for information, and actively solicits and responds appropriately to the Boards opinions, direction and advice. The Board expects nothing less.
Harold Brown |
Jennifer Li | Lucio A. Noto | ||
André Calantzopoulos |
Jun Makihara | Frederik Paulsen | ||
Louis C. Camilleri |
Sergio Marchionne | Robert B. Polet | ||
Massimo Ferragamo |
Kalpana Morparia | Stephen M. Wolf | ||
Werner Geissler |
4 PMI 2017 Proxy Statement
TABLE OF CONTENTS |
PMI 2017 Proxy Statement 5
GLOSSARY OF TERMS |
Financial Terms:
▪ | Net revenues exclude excise taxes. |
▪ | Operating Companies Income, or OCI, is defined as operating income, excluding general corporate expenses and the amortization of intangibles, plus equity (income) or loss in unconsolidated subsidiaries, net. |
▪ | Adjusted OCI is defined as reported OCI adjusted for asset impairment, exit and other costs. |
▪ | OCI growth rates are on an adjusted basis. |
▪ | EPS stands for Earnings Per Share. |
▪ | Adjusted Diluted EPS is defined as reported diluted EPS adjusted for asset impairment and exit costs, discrete tax items and unusual items. |
▪ | Free cash flow is defined as net cash provided by operating activities less capital expenditures. |
Other Terms:
▪ | Reduced-Risk Products (RRPs) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. We have a range of RRPs in various stages of development, scientific assessment and commercialization. Because our RRPs do not burn tobacco, they produce far lower quantities of harmful and potentially harmful compounds than found in cigarette smoke. |
▪ | NEOs are Named Executive Officers and include our Chief Executive Officer, or CEO, our Chief Financial Officer, or CFO, and the three other most highly compensated officers serving in 2016. |
▪ | PSUs are Performance Share Units. |
▪ | RSUs are Restricted Share Units, and may be issued in the form of deferred share awards. |
▪ | TSR stands for Total Shareholder Return. |
▪ | In this proxy statement, PMI, the Company, we, us, and our refer to Philip Morris International Inc. and its subsidiaries. |
▪ | We divide our markets into four geographic regions, which constitute our segments for financial reporting purposes: |
| The European Union, or EU, Region covers all the EU countries and also comprises Switzerland, Norway and Iceland, which are linked to the EU through trade agreements; |
| The Eastern Europe, Middle East & Africa, or EEMA, Region includes Eastern Europe, certain Balkan countries, Turkey, the Middle East and Africa and our international duty free business; |
| The Asia Region covers all other Asian markets as well as Australia, New Zealand and the Pacific Islands; and |
| The Latin America & Canada, or LA&C, Region covers the South American continent, Central America, Mexico, the Caribbean and Canada. |
6 PMI 2017 Proxy Statement
PROXY STATEMENT SUMMARY |
This proxy statement contains proposals to be voted on at our Annual Meeting, and other information about our Company and our corporate governance practices. We provide below a brief summary of certain information contained in this proxy statement. The summary does not contain all of the information you should consider. Please read the entire proxy statement carefully before voting.
2016 Business Performance Highlights
In 2016, we delivered strong results on our key performance metrics, while also achieving notable progress against our strategic initiatives. Our financial results were achieved despite significant volume declines in several markets, notably in Pakistan and the Philippines, where volume decreases were concentrated in low unit margin brands that had a limited impact on our bottom line. We more than offset lower shipment volumes through favorable pricing and better-than-anticipated RRP performance.
As further discussed on page 37, we also made significant progress on our strategic initiatives, with the standout achievement being the successful national roll-out of our IQOS Reduced-Risk Product platform in Japan, where IQOS heated tobacco sticks achieved a share of approximately 4.9% in the fourth quarter of 2016. An estimated 1.4 million adult smokers have already converted to IQOS, despite our restricting IQOS device sales due to temporary manufacturing capacity limitations on IQOS heated tobacco sticks. At year-end 2016, we were commercializing RRPs in key cities or nationally in 20 markets. Importantly, we made substantial progress on other fronts of RRP development, including scientific substantiation, underpinned by our Modified Risk Tobacco Product application to the U.S. Food and Drug Administration, product development, engagement with the public health communities, and the RRP regulatory and fiscal environment.
2016 Performance Targets and Results
PMI 2017 Proxy Statement 7
PROXY STATEMENT SUMMARY |
Investor Outreach
Throughout the year, the Company engages in an extensive shareholder outreach program during which it seeks input on a range of matters, including executive compensation and corporate governance. In 2015, the Compensation and Leadership Development Committee substantially revamped our executive compensation program in response to specific concerns raised by certain institutional shareholders and to the 2015 shareholder vote of 63.3% in support of the advisory say-on-pay proposal, a level that the Committee believed was inadequate. Our shareholders overwhelmingly supported the new compensation program, with the approval of 95.0% of the shares voted at the 2016 Annual Meeting. Based on this support and its own satisfaction with the new compensation program, the Compensation and Leadership Development Committee has determined not to make any substantial further modifications to the program at this time.
In 2016, we met with 65 of our top 100 institutional investors, representing 72% of our available global shareholder base (which excludes index and most pension funds), to discuss our business and environmental, social and governance issues. In addition to these regular Investor Relations engagements, we invited our 50 largest shareholders, holding approximately 52% of our shares, to participate in individual conference calls to discuss executive compensation and corporate governance. These engagements provided us a better understanding of our shareholders priorities, perspectives and positions. We reported the substance of these engagements to our Compensation and Leadership Development Committee, our Nominating and Corporate Governance Committee, and our entire Board of Directors.
The shareholders with whom we spoke overwhelmingly supported the new compensation program. They also commended the governance changes made in 2015, namely the new proxy access by-law, the adoption of share ownership guidelines for non-employee directors, the enhancements to the Companys anti-hedging and anti-pledging policies, and the formalization of the Nominating and Corporate Governance Committees oversight of the Companys lobbying and trade association activities and expenditures.
In September 2016, we held our biennial Investor Day, which was attended in person by sell-side analysts and by representatives of the holders of approximately 27% of our available global shareholder base. All shareholders were able to view the presentations by webcast. During this two-day conference, shareholders received detailed presentations about our business and had the opportunity to meet with and ask questions of our senior management team. Before the conference, we commissioned an independent third-party to survey sell-side analysts and institutional shareholders on a number of topics, including those they most wished to see addressed at the conference and any additional messages they wished to convey to management. The survey results were reported to us anonymously and addressed in the presentations. We reported the results of this conference to our Finance Committee and to our entire Board of Directors.
2017 Performance Incentive Plan
The Company is asking shareholders to approve the 2017 Performance Incentive Plan to replace its 2012 Performance Incentive Plan. The terms of the 2017 Plan are summarized beginning on page 60.
2017 Stock Compensation Plan for Non-Employee Directors
The Company is also asking shareholders to approve the 2017 Stock Compensation Plan for Non-Employee Directors to replace its 2008 Plan. The terms of the 2017 Plan are summarized beginning on page 64.
8 PMI 2017 Proxy Statement
PROXY STATEMENT SUMMARY |
Shareholder Agenda Items
2017 Shareholder Vote Recommendations
The Board of Directors makes the following recommendations to shareholders:
Boards Recommendation | Page | |||||
Item 1: |
Election of Directors |
FOR each nominee | 17 | |||
Item 2: |
Advisory Vote Approving Executive Compensation |
FOR | 58 | |||
Item 3: |
Advisory Vote on the Frequency of Future Say-on-Pay Votes |
EVERY YEAR | 59 | |||
Item 4: |
Approval of the 2017 Performance Incentive Plan |
FOR | 60 | |||
Item 5: |
Approval of the 2017 Stock Compensation Plan for Non-Employee Directors | FOR | 64 | |||
Item 6: |
Ratification of the Selection of Independent Auditors for 2017 |
FOR | 68 | |||
Item 7: |
Shareholder Proposal on Human Rights Policy |
AGAINST | 69 | |||
Item 8: |
Shareholder Proposal on Mediation of Alleged Human Rights Violations | AGAINST | 71 |
PMI 2017 Proxy Statement 9
BOARD OPERATIONS AND GOVERNANCE |
10 PMI 2017 Proxy Statement
BOARD OPERATIONS AND GOVERNANCE |
PMI 2017 Proxy Statement 11
BOARD OPERATIONS AND GOVERNANCE |
Committees and 2016 Meetings |
Current Members | Purpose, Authority and Responsibilities | ||||||
AUDIT
Meetings: 9 |
- Jennifer Li (Chair) - Werner Geissler - Jun Makihara - Lucio A. Noto - Stephen M. Wolf |
Purpose: to assist the Board in its oversight of: |
||||||
▪ |
the integrity of the financial statements and financial reporting processes and systems of internal control; |
|||||||
▪ |
the qualifications, independence and performance of the independent auditors; |
|||||||
▪ |
the internal audit function; and |
|||||||
▪ |
the Companys compliance with legal and regulatory requirements. |
|||||||
Authority and Responsibilities: |
||||||||
▪ |
sole authority for appointing, compensating, retaining and overseeing the work of the independent auditors; |
|||||||
▪ |
evaluate the internal audit function; |
|||||||
▪ |
evaluate the compliance function; |
|||||||
▪ |
oversee cybersecurity risk assessment and management; |
|||||||
▪ |
review financial risk assessment and management; |
|||||||
▪ |
oversee the risk management of excessive or discriminatory taxation; |
|||||||
▪ |
oversee the risk management of illicit trade; |
|||||||
▪ |
oversee the risk management of judicial and regulatory disregard for the rule of law; and |
|||||||
▪
|
establish whistleblower procedures and review claims of improper conduct.
|
|||||||
COMPENSATION AND LEADERSHIP DEVELOPMENT
Meetings: 5 |
- Werner Geissler (Chair) - Harold Brown - Lucio A. Noto - Robert B. Polet - Stephen M. Wolf |
Purpose: |
||||||
▪ | discharge the Boards responsibilities relating to executive compensation; |
|||||||
▪ | produce a report for inclusion in the proxy statement; and |
|||||||
▪ | review succession plans for the CEO and other senior executives. |
|||||||
Authority and Responsibilities: |
||||||||
▪ | review and approve the Companys overall compensation philosophy and design; |
|||||||
▪ | review and approve corporate goals and objectives relevant to the compensation of the CEO, evaluate his performance and determine and approve his compensation; |
|||||||
▪ | review and approve the compensation of all executive officers; |
|||||||
▪ | recommend to the Board compensation plans and administer and make awards under such plans and review the cumulative effect of its actions; |
|||||||
▪ | monitor compliance by executives with our share ownership requirements; |
|||||||
▪ | review and assist with the development of executive succession plans, evaluate and make recommendations to the Board regarding potential CEO candidates and evaluate and approve candidates to fill other senior executive positions; |
|||||||
▪ | oversee the management of risks related to compensation design and payout; |
|||||||
▪ | oversee talent management, particularly with respect to diversity and inclusion and talent development throughout the organization; |
|||||||
▪ | review and discuss with management proposed disclosures regarding executive compensation matters; and |
|||||||
▪ | recommend to the Board whether the Compensation Discussion and Analysis should be accepted for inclusion in the proxy statement and annual report. |
|||||||
FINANCE
Meetings: 4 |
- Jun Makihara (Chair) - Harold Brown - Massimo Ferragamo - Werner Geissler - Jennifer Li - Sergio Marchionne - Kalpana Morparia - Lucio A. Noto - Frederik Paulsen - Robert B. Polet - Stephen M. Wolf |
Purpose, Authority and Responsibilities: |
||||||
▪ | monitor the Companys financial performance and condition; |
|||||||
▪ | oversee sources and uses of cash flow and capital structure; |
|||||||
▪ | advise the Board on dividends, share repurchases and other financial matters; |
|||||||
▪ | advise the Board on the Companys long-term financing plans, short-term financing plans and credit facilities; |
|||||||
▪ | oversee the management of the Companys cash management function; |
|||||||
▪ | oversee the management of the Companys pension plans, including funded status and performance; |
|||||||
▪ | oversee the management of the Companys investor relations and stock market performance; |
|||||||
▪ | oversee the management of the risks to the Companys competitive position; |
|||||||
▪ | oversee the management of the risks to the Companys pricing strategies; and |
|||||||
▪
|
oversee the management of the risks of volatility in currency exchange rates.
|
12 PMI 2017 Proxy Statement
BOARD OPERATIONS AND GOVERNANCE |
Committees and 2016 Meetings |
Current Members | Purpose, Authority and Responsibilities | ||||||
NOMINATING AND CORPORATE GOVERNANCE
Meetings: 3 |
- Kalpana Morparia (Chair) - Jennifer Li - Lucio A. Noto - Robert B. Polet - Stephen M. Wolf |
Purpose: |
||||||
▪ |
identify qualified candidates for Board membership; |
|||||||
▪ |
recommend nominees for election at the Annual Meeting; |
|||||||
▪ |
advise the Board on corporate governance matters; and |
|||||||
▪ |
oversee self-evaluation of the Board and each Committee. |
|||||||
Authority and Responsibilities: |
||||||||
▪ |
review qualifications of prospective candidates for director; |
|||||||
▪ |
consider performance of incumbent directors; |
|||||||
▪ |
make recommendations to the Board regarding director independence and the function, composition and structure of the Board and its Committees; |
|||||||
▪ |
oversee the Companys lobbying and trade association activities and expenditures; |
|||||||
▪ |
recommend corporate governance guidelines; and |
|||||||
▪
|
review director compensation.
|
|||||||
PRODUCT INNOVATION AND REGULATORY AFFAIRS
Meetings: 3 |
- Harold Brown (Chair) - Massimo Ferragamo - Werner Geissler - Jun Makihara - Sergio Marchionne - Kalpana Morparia - Frederik Paulsen - Robert B. Polet - Stephen M. Wolf |
Purpose: |
||||||
▪ |
monitor and review the development of new product strategies, with a particular focus on Reduced-Risk Products; |
|||||||
▪ |
monitor and review key legislative, regulatory and public policy issues; and |
|||||||
▪ |
monitor and review the Companys programs on societal alignment issues. |
|||||||
Authority and Responsibilities: | ||||||||
▪ |
oversee the management of the risks of changing consumer preferences and the Companys ability to communicate to consumers; |
|||||||
▪ |
oversee the management of the risks associated with the Companys efforts to develop and commercialize RRPs; |
|||||||
▪ |
oversee the management of the risks associated with product diversification; and |
|||||||
▪
|
meet with the Companys Scientific Advisory Board to review scientific developments.
|
PMI 2017 Proxy Statement 13
BOARD OPERATIONS AND GOVERNANCE |
Risk oversight is conducted both by the Committees of the Board with respect to their areas of responsibility as well as by the full Board. During 2015, management conducted a reassessment of strategic enterprise risk. As part of this reassessment, the senior management team identified and prioritized key business risks based on four risk dimensions: the impact a risk could have on the organization if it occurs, the likelihood a risk will occur, the velocity with which a risk would affect the organization if it occurs, and the interconnectivity of a risk with other risks. As part of the risk management process, the Company established a Corporate Risk Governance Committee (CRGC) comprising the CFO, the Vice President and Controller, the Vice President, Corporate Audit, the Vice President and Chief Compliance Officer and the Vice President, Treasury and Corporate Finance. Ownership of each of the prioritized risks was assigned to a member of senior management, and oversight of the management of each risk was assigned to a particular Board Committee or to the full Board. Management reports on these risks to the appropriate Committee and to the full Board throughout the year. The risk management oversight by each Committee is indicated in the chart on pages 12 and 13. The full Board oversees the management of risks relating to the Companys business plan and litigation, and it receives reports on risk management by each Committee. The roles of the various components of risk assessment, management and oversight are shown below.
PMI Risk Assessment, Management and Oversight
14 PMI 2017 Proxy Statement
BOARD OPERATIONS AND GOVERNANCE |
PMI 2017 Proxy Statement 15
BOARD OPERATIONS AND GOVERNANCE |
Summary of Corporate Governance Practices
The Nominating and Corporate Governance Committee of the Board reviews our corporate governance practices regularly and proposes modifications to our principles and other key governance practices as warranted for adoption by the Board. The following summarizes our key principles and practices and refers you to the pages of this proxy statement where you will find a more detailed discussion of various items:
▪ | the Board has a policy providing that all directors are elected annually and by majority vote rather than by a plurality (see page 18); |
▪ | under our proxy access by-law, an eligible shareholder or group of shareholders who have owned 3% or more of PMIs shares for at least three years may nominate and include in our proxy statement director candidates to occupy up to 20% of the authorized Board seats; |
▪ | the Audit, Compensation and Leadership Development, and Nominating and Corporate Governance Committees consist entirely of independent directors, all other Board Committees consist entirely of non-management directors, and the Board has no executive committee; |
▪ | the Board elects the Chairman annually; |
▪ | the non-management directors elect the Presiding Director annually (see page 10); |
▪ | directors may be removed with or without cause; |
▪ | the non-management directors meet in executive session regularly without any members of management being present; |
▪ | the Board assesses its performance and the performance of Board Committees annually; |
▪ | PMI has not adopted a poison pill rights plan; |
▪ | the Board has adopted a clawback policy providing for the recovery of cash bonuses and equity compensation in appropriate circumstances (see page 44); |
▪ | the Board has adopted share ownership requirements and anti-hedging and anti-pledging policies for directors and executives intended to align their interests with those of our shareholders and to protect against inappropriate risk taking (see page 44); |
▪ | the Compensation and Leadership Development Committee has adopted a policy that in the event any equity award granted under the proposed 2017 Performance Incentive Plan vests on an accelerated basis upon the termination of an executive officers employment for any reason other than death or disability, the former officer must hold such shares for at least one year following termination (see page 44); |
▪ | we do not gross up the limited perquisites we provide our named executive officers to offset their taxes on imputed income; |
▪ | both the current and proposed Performance Incentive Plans include a double-trigger feature to the vesting provisions following a change in control as described on pages 57 and 62; and |
▪ | the Board has established independent oversight of political spending and lobbying that requires periodic reporting by management to the Nominating and Corporate Governance Committee with respect to the Companys lobbying and trade association activities and expenditures. |
16 PMI 2017 Proxy Statement
ELECTION OF DIRECTORS |
PMI 2017 Proxy Statement 17
ELECTION OF DIRECTORS |
18 PMI 2017 Proxy Statement
ELECTION OF DIRECTORS |
Current Committee Membership | ||||||||||||||||||||
Nominee | Director Since |
Nationality | Experience and Qualifications Highlights |
Independent | Audit | Compensation and Leadership Development |
Finance | Nominating and Corporate Governance |
Product Innovation and Regulatory Affairs | |||||||||||
Harold Brown |
2008 | USA | ▪ Civic Leadership ▪ Geopolitical and Governmental Affairs ▪ Science and Technology ▪ Academic and Research |
✓ | ✓ | ✓ | Chair | |||||||||||||
André Calantzopoulos |
2013 | Greece / Switzerland |
▪ Senior Executive ▪ Tobacco Industry ▪ Operations ▪ Global Business |
|||||||||||||||||
Louis C. Camilleri |
2008 | UK | ▪ Senior Executive ▪ Tobacco Industry ▪ Operations ▪ Financial ▪ Global Business |
|||||||||||||||||
Massimo Ferragamo |
2016 | Italy | ▪ Senior Executive ▪ Global Consumer and Luxury Products ▪ Marketing |
✓ | ✓ | ✓ | ||||||||||||||
Werner Geissler |
2015 | Germany | ▪ Global Consumer Products ▪ Senior Executive ▪ Operations ▪ Financial ▪ Civic Leadership |
✓ | ✓ | Chair | ✓ | ✓ | ||||||||||||
Jennifer Li |
2010 | China | ▪ Senior Executive ▪ Financial ▪ Technology ▪ Global Business |
✓ | Chair | ✓ | ✓ | |||||||||||||
Jun Makihara |
2014 | Japan | ▪ Global Business ▪ Global Finance |
✓ | ✓ | Chair | ✓ | |||||||||||||
Sergio Marchionne |
2008 | Italy / Canada |
▪ Senior Executive ▪ Financial ▪ Law ▪ Global Automotive Business |
✓ | ✓ | |||||||||||||||
Kalpana Morparia |
2011 | India | ▪ Senior Executive ▪ Global Finance ▪ Law ▪ Risk Management |
✓ | ✓ | Chair | ✓ | |||||||||||||
Lucio A. Noto |
2008 | USA | ▪ Senior Executive ▪ Operations ▪ Financial ▪ Global Business |
✓ (Presiding Director) |
✓ | ✓ | ✓ | ✓ | ||||||||||||
Frederik Paulsen |
2014 | Sweden | ▪ Global Pharmaceutical ▪ Senior Executive/ Entrepreneur ▪ Civic Leadership ▪ Academic and Research |
✓ | ✓ | ✓ |
PMI 2017 Proxy Statement 19
ELECTION OF DIRECTORS |
Director Nominees
Current Committee Membership | ||||||||||||||||||||
Nominee | Director Since |
Nationality | Experience and Qualifications Highlights |
Independent | Audit | Compensation and Leadership Development |
Finance | Nominating and Corporate Governance |
Product Innovation and Regulatory Affairs | |||||||||||
Robert B. Polet |
2011 | Netherlands | ▪ Senior Executive ▪ Global Consumer and Luxury Products ▪ Marketing |
✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||
Stephen M. Wolf |
2008 | USA | ▪ Senior Executive ▪ Global Business ▪ Operations |
✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
20 PMI 2017 Proxy Statement
ELECTION OF DIRECTORS |
Director Nominees
HAROLD BROWN
| ||
Primary Occupation: Counselor, Center for Strategic and International Studies
Director since: 2008
Age: 89 |
Professional Experience: Dr. Brown has been a Counselor at the Center for Strategic and International Studies since 1992. He was a partner of Warburg Pincus, a leading private equity firm, from 1990 until his retirement in 2007. Previously, he was Chairman of the Foreign Policy Institute at The Johns Hopkins University School of Advanced International Studies. Dr. Brown is President Emeritus of the California Institute of Technology and served as Secretary of Defense for the United States from 1977 through 1981.
Other Directorships and Associations: Dr. Brown is a member of the board of directors of Chemical Engineering Partners, Inc. and is president emeritus and life trustee of the California Institute of Technology, a member of the North American Group of the Trilateral Commission and a trustee emeritus of the RAND Corporation. Dr. Brown served as a director of Altria Group, Inc. from 1983 to April 2003, and again from December 2004 to March 2008.
PMI Board Committees: Dr. Brown is Chair of the Product Innovation and Regulatory Affairs Committee and a member of the Compensation and Leadership Development and Finance Committees.
Director Qualifications: Dr. Brown combines a scientists intellect with an extensive knowledge and unique experience of international geopolitical and governmental affairs that are of particular benefit to the Board in his role as Chair of the Product Innovation and Regulatory Affairs Committee.
|
ANDRÉ CALANTZOPOULOS
| ||
Primary Occupation: Chief Executive Officer
Director since: 2013
Age: 59
|
Professional Experience: Mr. Calantzopoulos became our Chief Executive Officer immediately following our Annual Meeting of Shareholders on May 8, 2013. He served as our Chief Operating Officer since our spin-off on March 28, 2008, and until becoming CEO. Mr. Calantzopoulos served as PMIs President and Chief Executive Officer between 2002 and the date of our spin-off. He joined the Company in 1985 and worked extensively across Central Europe, including as Managing Director of PM Poland and President of the EEMA Region.
Director Qualifications: Mr. Calantzopouloss intellect and all-encompassing knowledge of the Company serve him well as CEO and as a member of the Board. He has played an instrumental role in numerous key initiatives, including critical innovative developments, such as the new architecture that has revitalized the Marlboro brand, new product development, including Reduced-Risk Products, and revamped adult consumer engagement activities that drove our broad-based market share gains in both OECD and non-OECD markets.
|
PMI 2017 Proxy Statement 21
ELECTION OF DIRECTORS |
LOUIS C. CAMILLERI
| ||
Primary Occupation: Chairman of the
Director since: 2008
Age: 62
|
Professional Experience: Mr. Camilleri is our Chairman, having served as our Chairman and Chief Executive Officer from our spin-off in 2008 until the 2013 Annual Meeting of Shareholders. Mr. Camilleri remained as Chairman and an employee of the Company following the 2013 Annual Meeting. He retired effective December 31, 2014, and continues to serve as a non-employee Chairman. Before our spin-off, Mr. Camilleri was Chairman and Chief Executive Officer of Altria Group, Inc., positions he had held since 2002. From November 1996 to April 2002, he served as Senior Vice President and Chief Financial Officer of Altria Group, Inc. He had been employed continuously by Altria Group, Inc. and its subsidiaries (including Philip Morris International Inc.) in various capacities since 1978.
Other Directorships and Associations: Mr. Camilleri is a director of América Móvil, S.A.B. de C.V. and Ferrari N.V. He previously served on the Board of Telmex International SAB from December 2009 to April 2011. Mr. Camilleri was a director of Kraft Foods Inc. from March 2001 to December 2007 and was Krafts Chairman from September 2002 to March 2007.
Director Qualifications: Mr. Camilleris extensive and detailed knowledge of the Company and the tobacco industry and an incisive strategic view, combined with his transparency and open-mindedness, serve him well in his ongoing role as Chairman of the Board.
|
MASSIMO FERRAGAMO
| ||
Primary Occupation: Chairman, Ferragamo USA Inc.
Director since: 2016
Age: 59
|
Professional Experience: Mr. Ferragamo has served as Chairman of Ferragamo USA Inc. since 2000, having previously served as President of that company since 1985. Mr. Ferragamo is also Vice President of the Lungarno Hotel Group and Executive Vice President of the Ferragamo Foundation.
Other Directorships and Associations: Mr. Ferragamo is a director of Ferragamo Finanziaria S.p.A. Mr. Ferragamo served on the board of directors of Yum! Brands, Inc. from 1997 until 2016.
PMI Board Committees: Mr. Ferragamo is a member of the Finance and Product Innovation and Regulatory Affairs Committees.
Director Qualifications: Mr. Ferragamos entrepreneurial spirit and deep experience in the global luxury consumer products business will complement the considerable expertise of our formidable Board of Directors in the years to come.
|
22 PMI 2017 Proxy Statement
ELECTION OF DIRECTORS |
WERNER GEISSLER
| ||
Primary Occupation: Operating Partner, Advent International
Director since: 2015
Age: 63
|
Professional Experience: Mr. Geissler became an Operating Partner of Advent International in 2015. He previously served as Vice Chairman and Special Advisor to the Chairman and CEO of Procter and Gamble until his retirement in January 2015. He joined that company in 1979 and served in various capacities, including President, Northeast Asia, from 2001 to 2004, Group President, Central and Eastern Europe, Middle East and Africa, from 2004 to 2007, and Vice Chairman, Global Operations, from 2007 to 2014.
Other Directorships and Associations: Mr. Geissler is a director of the Goodyear Tire and Rubber Company.
PMI Board Committees: Mr. Geissler is Chair of the Compensation and Leadership Development Committee and a member of the Audit, Finance, and Product Innovation and Regulatory Affairs Committees.
Director Qualifications: Mr. Geissler has a keen knowledge of the global consumer products business, having served as a senior consumer products executive in many of the Companys most important markets and regions. His deep senior executive experience serves him well as Chair of the Compensation and Leadership Development Committee.
|
JENNIFER LI
| ||
Primary Occupation: Chief Financial Officer, Baidu, Inc.
Director since: 2010
Age: 49
|
Professional Experience: Ms. Li joined Baidu, Inc., the largest Internet search engine in China and the third-largest independent search engine in the world, in March 2008, as Chief Financial Officer, responsible for a wide range of corporate functions, including Finance, Human Resources, International Operations, Marketing, Communications and Purchasing. Previously, from 1994 to 2008, she held a number of senior finance positions at various General Motors companies in China, Singapore, the United States and Canada, rising to Chief Financial Officer of GMs business in China and Financial Controller of the North American Operations of GMAC.
PMI Board Committees: Ms. Li is the Chair of the Audit Committee and a member of the Finance and Nominating and Corporate Governance Committees.
Director Qualifications: Ms. Li draws upon her strong financial and accounting expertise as Chair of the Audit Committee, and her experience in a fast-growing, high-tech business and Asian background strengthen the Boards depth and global perspective.
|
PMI 2017 Proxy Statement 23
ELECTION OF DIRECTORS |
JUN MAKIHARA
| ||
Primary Occupation: Retired Businessman
Director since: 2014
Age: 59 |
Professional Experience: Mr. Makihara was employed at Goldman, Sachs & Co. from 1981 to 2000, during which time he was a General Partner for six years, working in New York, Los Angeles, and Tokyo. During his tenure in Tokyo, he was co-head of the Investment Banking Group and the Japanese Equities Group and also served as co-branch manager. Subsequently, he was Chairman of Neoteny Co., Ltd., a Japanese venture incubator until 2015.
Other Directorships and Associations: Mr. Makihara is a director of Monex Group, Inc. and Shinsei Bank, Ltd. He is a trustee of the Protestant Episcopal Cathedral Foundation in Washington, D.C. and a board member of the Japan Society in New York. He also served on the board of RHJ International S.A. from 2005 to 2014.
PMI Board Committees: Mr. Makihara is Chair of the Finance Committee and a member of the Audit and Product Innovation and Regulatory Affairs Committees.
Director Qualifications: Mr. Makihara brings his deep experience in finance to his position as Chair of the Finance Committee, and the Board benefits from his entrepreneurial spirit and a thorough knowledge of business in Asia, one of the Companys most important segments.
|
SERGIO MARCHIONNE
| ||
Primary Occupation: Chief Executive Officer, Fiat Chrysler Automobiles N.V.
Chairman, Ferrari N.V.
Chairman, CNH Industrial N.V.
Director since: 2008
Age: 64 |
Professional Experience: Mr. Marchionne is Chief Executive Officer of Fiat Chrysler Automobiles N.V., having become a member of the Board of Directors of a predecessor of that company, Fiat S.p.A., in May 2003. He is also Chairman of Ferrari N.V. and CNH Industrial N.V. Mr. Marchionne has been a member of the Board of SGS S.A. since May 2001, serving as the Chief Executive and Managing Director from 2002 to 2004 and Chairman since March 2006. Mr. Marchionne is a director of Exor S.p.A., an investment company that, directly or indirectly, holds significant equity investments in Fiat Chrysler and CNH. Mr. Marchionne is a chartered accountant and lawyer who, since beginning his career in 1983, has held executive positions at several firms prior to assuming his current positions.
Other Directorships and Associations: Mr. Marchionne was a member of the Board of Directors of UBS from 2007 to 2010.
PMI Board Committees: Mr. Marchionne serves on the Finance and Product Innovation and Regulatory Affairs Committees.
Director Qualifications: Trained as both a lawyer and an accountant and currently the chief executive of an international automotive manufacturer, Mr. Marchionne brings strategic insights and a hands-on multi-disciplinary approach to the Board, along with experience in many of the same international markets in which the Company does business.
|
24 PMI 2017 Proxy Statement
ELECTION OF DIRECTORS |
KALPANA MORPARIA
| ||
Primary Occupation: Chief Executive Officer, South and South East Asia J.P. Morgan Chase
Director since: 2011
Age: 67 |
Professional Experience: Ms. Morparia assumed her current position in April 2016, having previously served as CEO of J.P. Morgan India since 2008. She is a member of J.P. Morgans Asia Pacific Management Committee. Prior to joining J.P. Morgan India, Ms. Morparia served as Joint Managing Director of ICICI Bank, Indias second-largest bank, from 2001 to 2007 and the Vice Chair of ICICIs insurance and asset management business from 2007 to 2008.
Other Directorships and Associations: Ms. Morparia is a director of Dr. Reddys Laboratories Ltd. and Hindustan Unilever Limited.
PMI Board Committees: Ms. Morparia is Chair of the Nominating and Corporate Governance Committee and is a member of the Finance and Product Innovation and Regulatory Affairs Committees.
Director Qualifications: With her strong executive leadership experience in finance, and her deep knowledge of international business, Ms. Morparia provides a keen perspective on economies in Asia, while her legal background and deep experience in highly regulated industries serve her well as Chair of the Nominating and Corporate Governance Committee.
|
LUCIO A. NOTO
| ||
Primary Occupation: Managing Partner, Midstream Partners, LLC
Director since: 2008
Age: 78 |
Professional Experience: Mr. Noto assumed his current position with Midstream Partners, LLC in March 2001. He retired as Vice Chairman of ExxonMobil Corporation in January 2001, a position he had held since the merger of the Exxon and Mobil companies in November 1999. Before the merger, Mr. Noto was Chairman and Chief Executive Officer of Mobil Corporation. Mr. Noto had been employed by Mobil continuously since 1962.
Other Directorships and Associations: Mr. Noto is a director of Penske Automotive Group, Inc. He also served on the boards of IBM from 1995 to 2008, Altria Group, Inc. from 1998 to 2008, Shinsei Bank from 2005 to 2008, Commercial International Bank from 2006 to 2009 and RHJ International S.A. from 2011 to 2015.
PMI Board Committees: Mr. Noto is the Presiding Director, and a member of the Audit, Compensation and Leadership Development, Finance and Nominating and Corporate Governance Committees.
Director Qualifications: As the former chief financial officer and chief executive officer of a large, multi-national oil company, together with his past governance experience serving on the boards and audit committees of a number of major international companies, Mr. Noto brings an extensive knowledge of internal controls and risk assessment to his Audit Committee role and a strong hands-on approach as Presiding Director.
|
PMI 2017 Proxy Statement 25
ELECTION OF DIRECTORS |
FREDERIK PAULSEN
| ||
Primary Occupation: Chairman, Ferring Group
Director since: 2014
Age: 66 |
Professional Experience: Dr. Paulsen has been Chairman of the Ferring Group, a research-driven, specialty biopharmaceutical group, since 1988, having joined that company in 1976.
Other Directorships and Associations: Dr. Paulsen is a member of the boards of MGIMO University in Moscow, Russia, and the Pro Universitate of the Christian Albrechts University in Kiel, Germany, and a trustee of the Salk Institute of Biological Research in La Jolla, California, USA.
PMI Board Committees: Dr. Paulsen is a member of the Finance and Product Innovation and Regulatory Affairs Committees.
Director Qualifications: Dr. Paulsens substantial experience as head of a successful multinational biopharmaceutical group, together with his scientific background, bring a unique perspective to the Companys critical efforts to develop Reduced-Risk Products.
|
ROBERT B. POLET
| ||
Primary Occupation: Chairman, Safilo Group S.p.A.
Chairman, Rituals B.V.
Director since: 2011
Age: 61 |
Professional Experience: Mr. Polet is currently serving as Chairman of Safilo Group S.p.A. He was President, Chief Executive Officer and Chairman of the Management Board of the Gucci Group from 2004 until March 2011. Previously, Mr. Polet spent 26 years in the Unilever Group in a variety of executive roles, including President of Unilevers Worldwide Ice Cream and Frozen Foods division, Chairman of Unilever Malaysia, Chairman of Van den Bergh and Executive Vice President of Unilevers European Home and Personal Care division.
Other Directorships and Associations: Mr. Polet is a director of William Grant & Sons Limited and Arica Holding B.V. and the chairman of Rituals B.V.
PMI Board Committees: Mr. Polet serves on the Compensation and Leadership Development, Finance, Nominating and Corporate Governance, and Product Innovation and Regulatory Affairs Committees.
Director Qualifications: In his previous position, Mr. Polet was responsible for managing such global luxury brands as Gucci, Bottega Veneta, Yves Saint Laurent, Boucheron, Balenciaga, Sergio Rossi, Alexander McQueen and Stella McCartney. He brings to the Board his considerable entrepreneurial business experience in the global luxury business and his deep executive background running major consumer packaged goods businesses, as well as his extensive knowledge of global markets.
|
26 PMI 2017 Proxy Statement
ELECTION OF DIRECTORS |
STEPHEN M. WOLF
| ||
Primary Occupation: Managing Partner, Alpilles, LLC
Director since: 2008
Age: 75 |
Professional Experience: Mr. Wolf has been Managing Partner of Alpilles, LLC since April 2003. Previously, he was Chairman of US Airways Group from November 2001 to April 2003, and Chief Executive Officer of US Airways, Inc. from January 1996 to November 1998. Prior to joining US Airways, he had served since August 1994 as senior advisor in the investment banking firm of Lazard Frères & Co., LLC. From 1987 to July 1994, he was Chairman and Chief Executive Officer of UAL Corporation and United Air Lines, Inc.
Other Directorships and Associations: Mr. Wolf is Chairman of the Advisory Board of Trilantic Capital Partners and a director of Fiat Chrysler Automobiles N.V. Mr. Wolf served as Chairman of R.R. Donnelley & Sons Company from 2004 to 2014. From 1993 to 2008, Mr. Wolf served as a director of Altria Group, Inc. He is a trustee emeritus of the Brookings Institute.
PMI Board Committees: Mr. Wolf is a member of the Audit, Compensation and Leadership Development, Finance, Nominating and Corporate Governance, and Product Innovation and Regulatory Affairs Committees.
Director Qualifications: As a former chief executive officer of four New York Stock Exchange listed companies, and with experience on the boards of a number of companies, Mr. Wolf provides strong counsel on a wide array of matters.
|
PMI 2017 Proxy Statement 27
COMPENSATION OF DIRECTORS |
Directors who are full-time employees of the Company receive no additional compensation for services as a director. The Companys philosophy is to provide competitive compensation necessary to attract and retain high-quality non-employee directors. The Board believes that a substantial portion of director compensation should consist of equity-based compensation to assist in aligning directors interests with the interests of shareholders.
The Nominating and Corporate Governance Committee periodically benchmarks director compensation against the Companys Peer Group (discussed on page 43), considers the appropriateness of the form and amount of director compensation and makes recommendations to the Board concerning such compensation with a view to attracting and retaining qualified directors. Based on the latest available data, total compensation for the Companys non-employee directors ranked in the top quartile of the Companys Peer Group.
At his request, Dr. Paulsen serves as a director without compensation. Except for the Chairman, all other non-employee directors receive an annual cash retainer of $125,000 and a retainer of $5,000 for each Committee of which they are a member. The Chairman receives an annual cash retainer of $1.25 million. The Presiding Director receives an additional annual retainer of $25,000 and the chairs of each Committee receive an additional annual retainer of $35,000 for services rendered in connection with those responsibilities. Directors do not receive meeting fees or stock options. |
Summary of Directors Compensation
PMI provides competitive compensation levels to attract and retain high-quality non-employee directors, and it uses a substantial component of equity-based compensation.
Compensation levels are benchmarked to our Peer Group.
|
| ||||||||
Annual cash retainer: |
$125,000 | |||||||||
Annual equity award: |
|
$175,000 |
| |||||||
Chairman annual cash retainer: |
|
$1,250,000 |
| |||||||
Chairman annual equity award: |
|
$1,250,000 |
| |||||||
Presiding Director cash retainer: |
|
$25,000 |
| |||||||
Committee Chair cash retainer: |
|
$35,000 |
| |||||||
Committee member cash retainer: |
|
$5,000 |
| |||||||
Committee meeting fees: |
|
None |
| |||||||
Stock options: |
|
None |
| |||||||
The Chairmans compensation reflects the Committees view of the value he brings to the Company, based on his deep knowledge of our business acquired during his 39 years of service to the Company and its former affiliates. It also reflects his substantial time commitment in fulfilling the duties of Chairman.
|
|
Pursuant to the 2008 PMI Stock Compensation Plan for Non-Employee Directors, each non-employee director then in office (except for Dr. Paulsen) received an annual equity award on May 4, 2016, of shares of common stock having a value of $175,000 on the date of grant (1,782 shares of common stock with a value of $98.225 per share). As a non-employee Chairman, Mr. Camilleri received an annual equity award having a value of $1.25 million.
A non-employee director may not sell or otherwise dispose of PMI shares received pursuant to the annual equity award (other than shares withheld from the grant to pay taxes) unless he or she continues after the disposition to own PMI shares having an aggregate value of at least five times the then-current annual cash retainer. The Companys anti-hedging and anti-pledging policies also apply to non-employee directors (See page 44).
28 PMI 2017 Proxy Statement
COMPENSATION OF DIRECTORS |
The following table presents the compensation received by the non-employee directors for fiscal year 2016.
Name | Fees Earned or Paid in Cash ($) |
Equity ($) |
Personal Use of Company Aircraft ($) (a) |
Car Expenses ($) (b) |
All Other ($) |
Total ($) |
||||||||||||
Harold Brown
|
|
175,000
|
|
|
175,000
|
|
-
|
-
|
-
|
|
350,000
|
| ||||||
Louis C. Camilleri
|
|
1,250,000
|
|
|
1,250,000
|
|
185,470
|
23,710
|
-
|
|
2,709,180
|
| ||||||
Massimo Ferragamo (c)
|
|
9,750
|
|
|
87,500
|
|
-
|
-
|
-
|
|
97,250
|
| ||||||
Werner Geissler
|
|
171,250
|
|
|
175,000
|
|
-
|
-
|
-
|
|
346,250
|
| ||||||
Jennifer Li
|
|
175,000
|
|
|
175,000
|
|
-
|
-
|
-
|
|
350,000
|
| ||||||
Jun Makihara
|
|
166,250
|
|
|
175,000
|
|
-
|
-
|
-
|
|
341,250
|
| ||||||
Sergio Marchionne
|
|
135,000
|
|
|
175,000
|
|
-
|
-
|
-
|
|
310,000
|
| ||||||
Kalpana Morparia
|
|
175,000
|
|
|
175,000
|
|
-
|
-
|
-
|
|
350,000
|
| ||||||
Lucio A. Noto
|
|
178,750
|
|
|
175,000
|
|
-
|
-
|
-
|
|
353,750
|
| ||||||
Frederik Paulsen (d)
|
|
-
|
|
|
-
|
|
-
|
-
|
-
|
|
-
|
| ||||||
Robert B. Polet
|
|
145,000
|
|
|
175,000
|
|
-
|
-
|
-
|
|
320,000
|
| ||||||
Stephen M. Wolf
|
|
158,750
|
|
|
175,000
|
|
-
|
-
|
-
|
|
333,750
|
|
(a) | For reasons of security and personal safety, PMI requires Mr. Camilleri to use Company aircraft for all travel. The amounts shown are the incremental cost of personal use of Company aircraft to PMI and include the cost of trip-related crew hotels and meals, in-flight food and beverages, landing and ground handling fees, hourly maintenance contract costs, hangar or aircraft parking costs, fuel costs based on the average annual cost of fuel per hour flown, and other smaller variable costs. Fixed costs that would be incurred in any event to operate Company aircraft (e.g., aircraft purchase costs, depreciation, maintenance not related to personal trips, and flight crew salaries) are not included. Mr. Camilleri has agreed to reimburse the Company for his personal usage of Company aircraft to the extent that the aggregate incremental cost of such usage exceeds $200,000 per fiscal year. He is responsible for his own taxes on any imputed taxable income resulting from personal use of Company aircraft. |
(b) | The amount shown for Mr. Camilleri includes the incremental cost of personal use of driver services that PMI provided for reasons of security and personal safety. Mr. Camilleri is responsible for his own taxes on any imputed taxable income resulting from car expenses. |
(c) | Mr. Ferragamos cash retainer and equity award were pro-rated to reflect his joining the Board in December 2016. |
(d) | At his request, Dr. Paulsen serves as a director without compensation. |
PMI 2017 Proxy Statement 29
STOCK OWNERSHIP INFORMATION |
Ownership of Equity Securities
The following table shows the number of shares of common stock beneficially owned as of March 10, 2017, by each director, nominee for director and named executive officer, and the directors and executive officers of the Company as a group. Unless otherwise indicated, each of the named individuals has sole voting and investment power with respect to the shares shown. The beneficial ownership of each director, nominee for director and executive officer, and of the directors, nominees for director and executive officers as a group, is less than 1% of the outstanding shares.
Name | Amount and Nature of Beneficial Ownership (1) |
|||
Harold Brown
|
|
52,908
|
| |
André Calantzopoulos
|
|
752,671
|
| |
Louis C. Camilleri
|
|
753,806
|
| |
Massimo Ferragamo
|
|
1,005
|
| |
Marc Firestone
|
|
177,643
|
| |
Werner Geissler
|
|
5,279
|
| |
Martin King
|
|
146,033
|
| |
Jennifer Li
|
|
17,672
|
| |
Jun Makihara
|
|
9,025
|
| |
Sergio Marchionne
|
|
63,614
|
| |
Kalpana Morparia
|
|
10,702
|
| |
Lucio A. Noto
|
|
95,524
|
| |
Jacek Olczak
|
|
226,486
|
| |
Frederik Paulsen
|
|
-
|
| |
Robert B. Polet
|
|
12,231
|
| |
Stephen M. Wolf
|
|
80,654
|
| |
Miroslaw Zielinski
|
|
209,293
|
| |
Group (28 persons)
|
|
3,503,522
|
|
(1) | Includes shares of deferred stock as follows: Dr. Brown, 33,119; Mr. Calantzopoulos, 188,170; Mr. Camilleri, 29,332; Mr. Ferragamo, 1,005; Mr. Firestone, 63,350; Mr. King, 30,230; Mr. Makihara, 5,665; Mr. Noto, 55,946; Mr. Olczak, 59,210; Mr. Wolf, 57,332; Mr. Zielinski, 39,370; and group, 771,369. Also includes 17,085 shares as to which beneficial ownership is disclaimed by Mr. Noto (shares held by spouse) and 22,196 shares held in trust as to which he has not disclaimed beneficial ownership. Also includes 1,360 shares as to which beneficial ownership is disclaimed by Mr. Makihara (shares held by spouse). Also includes 19,789 shares held in trust as to which Dr. Brown shares voting and/or investment power with others and as to which he has not disclaimed beneficial ownership. |
In addition to the shares shown in the table above, as of March 10, 2017, those directors who participate in the Companys director deferred fee program had the following PMI share equivalents allocated to their accounts: Mr. Ferragamo, 106; Mr. Makihara, 4,161; Mr. Noto, 86,755; and Mr. Wolf, 29,261. See Compensation of Directors on page 29 for a description of the deferred fee program for directors.
30 PMI 2017 Proxy Statement
STOCK OWNERSHIP INFORMATION |
The following table sets forth information regarding persons or groups known to the Company to be beneficial owners of more than 5% of the outstanding common stock.
Name and Address of Beneficial Owner | Number of Shares Beneficially Owned |
Percent of Common March 10, 2017 | ||||||||
BlackRock, Inc. 55 East 52nd Street New York, NY 10055
|
89,268,611 | (1) | 5.75 | % | ||||||
The Vanguard Group 100 Vanguard Blvd. Malvern, PA 19355
|
|
104,668,333 |
(2) |
|
6.74 |
% |
(1) | According to a Schedule 13G/A, dated January 25, 2017, filed with the U.S. Securities and Exchange Commission on January 25, 2017, by BlackRock, Inc. presenting the number of shares as of December 31, 2016. |
(2) | According to a Schedule 13G/A, dated February 9, 2017, filed with the U.S. Securities and Exchange Commission on February 13, 2017, by The Vanguard Group presenting the number of shares as of December 31, 2016. |
Section 16(a) Beneficial Ownership Reporting Compliance
The Company believes that during 2016 all reports for the Companys executive officers and directors that were required to be filed under Section 16 of the Securities Exchange Act of 1934 were filed on a timely basis, except that the purchase of 1,000 shares on November 17, 2016, by Mr. Patrick Brunel was inadvertently reported late.
PMI 2017 Proxy Statement 31
COMPENSATION DISCUSSION AND ANALYSIS |
Our Compensation Discussion and Analysis outlines the design of our executive compensation program components, the objectives and principles upon which they are based, our 2016 performance and the resulting decisions of the Compensation and Leadership Development Committee to reflect that performance in setting compensation for our CEO, the other named executive officers, and the other members of our senior management team.
Compensation and Leadership Development Committee
The Compensation and Leadership Development Committee consists entirely of non-management directors, all of whom our Board has determined are independent within the meaning of the listing standards of the New York Stock Exchange. Its responsibilities are described below and set forth in the Compensation and Leadership Development Committee Charter, which is available on the Companys website at www.pmi.com/governance. The members of the Committee are: Werner Geissler (Chair), Harold Brown, Lucio A. Noto, Robert B. Polet and Stephen M. Wolf. The Committee met five times in 2016. The Chair of the Committee, in consultation with the other members, sets meeting agendas. The Committee reports its actions and recommendations to the Board.
Program Design, Philosophy and Objectives
32 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
Components of Our Total Direct Compensation Program
Component | Key Characteristics | Key Objective | ||||||||||
Base Salary | ▪ |
Fixed component of compensation reflecting the scope of the executives role, performance and market pay practices. |
▪ |
Intended to provide sufficient competitive base pay to attract, develop and retain world-class leaders.
|
||||||||
Incentive Compensation (IC) Awards | ▪ |
Annual performance-based variable cash award for meeting or exceeding performance goals pre-established by the Committee. |
▪ |
Intended to motivate executives to meet or exceed our performance goals and strategic objectives in a given fiscal year. |
||||||||
▪ |
The Companys incentive compensation business rating is determined by a fixed formula that measures the Companys results against performance targets pre-established and pre-weighted by the Committee (see page 38). The final award is determined by multiplying the executives base salary by the IC business rating and by the executives IC target and individual performance rating.
|
|||||||||||
Equity Awards | ▪ |
Long-term variable equity awards contribute to all six of the Committees program design objectives while minimizing share dilution and protecting against excessive risk taking. |
▪ |
Intended to motivate our executives to produce results that enhance sustainable shareholder value and strengthen the Company over the long-term. |
||||||||
▪ |
Amount of each award is determined by multiplying the executives base salary by the target percentage for that salary grade, and then by the executives individual performance rating, plus or minus ten percentage points, for the most recently completed year.
for the February 2017 grant, 60% of the award was in the form of PSUs that vest at the end of the 2017-2019 performance cycle in amounts that depend on the degree to which pre-established and pre-weighted performance goals are achieved or exceeded (see pages 39-40).
40% of the February 2017 award was granted in the form of RSUs that vest at the end of the three-year cycle (assuming continued employment).
|
PMI 2017 Proxy Statement 33
COMPENSATION DISCUSSION AND ANALYSIS |
Changes in Compensation Structure
34 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
Target Compensation Mix
All of our NEOs are in salary grades 28 to 25. Our CEO is the only employee in salary grade 28, and no employee is in salary grade 27. The target compensation mix for 2016 and for 2017 is shown in the following chart:
In February 2017, the Committee granted PSUs for the 2017-2019 performance cycle and RSUs. It also established performance targets for the 2017 annual incentive compensation awards that are payable in February 2018. Award targets as a percentage of base salary for our CEO and our named executive officers are unchanged from 2016:
2017 Cash Incentive Target as % of Base Salary (1) |
2017-19 Performance Share as % of Base Salary (60% of total Equity Award) (2) |
2017 Restricted Share Units as % of Base Salary (40% of total Equity Award) (3) | ||||
André Calantzopoulos (CEO)
|
200%
|
360%
|
240%
| |||
Marc Firestone
|
125%
|
165%
|
110%
| |||
Martin King
|
100%
|
105%
|
70%
| |||
Jacek Olczak
|
125%
|
165%
|
110%
| |||
Miroslaw Zielinski
|
100%
|
105%
|
70%
|
(1) | Possible award range is between 0 and 225% of target. |
(2) | Possible award grant range is between 0 and 150% of target; between 0 and 200% of PSUs granted may vest, depending on performance versus criteria established at the time of grant. |
(3) | Possible award grant range is between 0 and 150% of target. |
PMI 2017 Proxy Statement 35
COMPENSATION DISCUSSION AND ANALYSIS |
36 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
PMI 2017 Proxy Statement 37
COMPENSATION DISCUSSION AND ANALYSIS |
IC Business Performance Rating: The Committee employed the following pre-established matrix that assigned a rating of 100 correlating to attaining the targeted performance. Ratings for each factor can range from 0 to 150. The percentages indicated for net revenues, adjusted OCI, adjusted diluted EPS, and free cash flow represent growth versus 2015 results. Actual results are shown in the blue boxes.
2016 Performance Versus Target
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rating: | 0 | 40 ... 80 | 90 | 95 | 100 | 108 | 110 | 115 | 117 | 120 | 130 | 140 | 150 | |||||||||||||||||||||||||||||||||||||||||||
Measure (a)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Share (Top 30 OCI (b)
|
<8 | 8 | 14 | 16 | 17 | 18 | 20 | 22 | 24 | 27 | 30 | |||||||||||||||||||||||||||||||||||||||||||||
Net Revenues (c) |
<1.4% | 1.4% | 3.0% | 3.8% | 4.2% | 4.4% | 4.7% | 5.1% | 5.5% | 5.9% | ||||||||||||||||||||||||||||||||||||||||||||||
Adjusted OCI (d) |
<4.2% | 4.2% | 7.0% | 8.3% | 9.4% | 10.3% | 10.6% | 11.5% | 12.3% | 13.2% | ||||||||||||||||||||||||||||||||||||||||||||||
Adjusted Diluted EPS (e) |
<6.1% | 6.1% | 9.3% | 10.9% | 11.8% | 12.0% | 13.3% | 14.3% | 15.2% | 16.1% | ||||||||||||||||||||||||||||||||||||||||||||||
Free Cash Flow (f) |
<(2.3)% | (2.3)% | 1.2% | 3.0% | 4.2% | 4.9% | 5.7% | 6.7% | 7.7% | 8.7% | ||||||||||||||||||||||||||||||||||||||||||||||
Strategic Initiatives |
110 |
(a) | For a reconciliation of non-GAAP to GAAP financial measures see Exhibit D to this proxy statement. |
(b) | Number of top 30 OCI markets in which share was growing or stable. |
(c) | Excluding excise taxes, currency and acquisitions. |
(d) | Excluding currency and acquisitions. |
(e) | Excluding currency. |
(f) | Net cash provided by operating activities less capital expenditures and excluding currency. |
Our performance rating for each factor was weighted in accordance with the pre-established formula shown below to produce an overall IC business rating.
2016 IC Business Rating
| ||||||
Measure | Performance Rating |
Weight |
Weighted Performance Rating | |||
Market Share (Top 30 OCI Markets)
|
95
|
15%
|
14.25
| |||
Net Revenues
|
115
|
15%
|
17.25
| |||
Adjusted OCI
|
117
|
15%
|
17.55
| |||
Adjusted Diluted EPS
|
108
|
20%
|
21.60
| |||
Free Cash Flow
|
115
|
20%
|
23.00
| |||
Strategic Initiatives
|
110
|
15%
|
16.50
|
38 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
In addition to certifying the IC business performance rating, the Committee rated each executive officers personal performance during 2016. Individual ratings can range from 0% to 150%. To assure a disciplined, fair and equitable assessment, individual performance ratings were calibrated to reflect each executives contribution to the overall results of the Company. Application of the following formula then determined the cash incentive award for each named executive officer in 2016.
Incentive Compensation Award Formula
IC Award |
= | Base Salary |
X | Individual Target % (varies by grade) |
X | IC Business Rating (0%-150%) |
X | Individual Rating (0%-150%) |
2017 Incentive Compensation (IC) Awards: For 2017, the Committee retained the six performance metrics used in 2016 except it changed free cash flow to operating cash flow, which is a U.S. GAAP measure and it set performance targets for those metrics. Each of the 2017 performance targets reflects the Companys 2017 budget approved by the Board, with a performance factor of 100 equating to achieving budgeted results. The full range of potential results is reflected in a pre-established matrix that will generate an overall IC business performance rating for 2017. In addition to pre-establishing a formula for grading our results against the performance factors, the Committee pre-established the weights for each factor.
Long-Term Equity Awards: The Committee establishes the equity award target opportunity for our CEO and each NEO based on Company targets by salary grade, which are unchanged from the levels established in 2014, and the individuals performance rating for this award. The Committee grants the individual 40% of the award opportunity in the form of time-based RSUs and 60% in the form of performance-based PSUs.
Equity Award Grant Formula
Equity Award Target Opportunity (40% RSU & 60% PSU) |
= | Base Salary |
X | Individual Target % (varies by |
X | Individual Rating (0%-150%) |
PSU Performance Metrics: The Committee established three metrics for determining the number of PSUs that will vest at the end of the 2017-2019 performance cycle. The first measure, which is weighted at 50%, is the Companys Total Shareholder Return during the three-year cycle relative to the Peer Group and on an absolute basis. The second measure, which is weighted at 30%, is the Companys currency-neutral compound annual adjusted OCI growth rate over the cycle, excluding acquisitions. The final measure, which is weighted 20%, is the Companys performance against a specific RRP volume measure for PMIs transformation to Reduced-Risk Products during the performance cycle. The Committee believes that these performance measures are the most appropriate factors in terms of incentivizing senior management to produce results that enhance sustainable shareholder value and strengthen the Company over the long term.
The aggregate of the weighted performance factors for the three metrics will determine the percentage of PSUs that vest at the end of the three-year performance cycle. Each vested PSU entitles the participant to one share of common stock. An aggregate weighted PSU performance factor of 100 will result in the targeted number of PSUs being vested. The minimum percentage of PSUs that can vest is zero, while the maximum is twice the targeted number.
PMI 2017 Proxy Statement 39
COMPENSATION DISCUSSION AND ANALYSIS |
TSR Performance Factor. The TSR performance factor, which determines 50% of the PSU payout, will be calculated based on the Companys three-year rolling TSR versus the Companys Peer Group (see page 43). To adjust for market volatility, the TSR calculations will be based on the average of the 20 trading days immediately before the start of the performance cycle and the last 20 trading days of the performance cycle. To reflect that several members of the Peer Group are primarily listed on foreign stock exchanges and report their financial results in different currencies, the Company will measure the TSRs for those companies by using the price performance of their publicly traded American Depository Receipts (U.S. ADRs). The use of U.S. ADRs will avoid the need to adjust the TSRs of non-U.S. Peers to reflect currency changes, and will increase transparency by enabling shareholders to directly observe such TSRs. The TSR performance factor for the 2017-2019 performance cycle will be calculated relative to the Peer Group in accordance with the following schedule, with linear interpolation for results between the 25th and 85th percentiles:
PMI TSR as a Percentile of Peer Group
|
Performance Factor
| |||
Below Threshold
|
Below 25th percentile
|
0%
| ||
Threshold
|
25th percentile
|
50%
| ||
Target
|
50th percentile
|
100%
| ||
Maximum
|
85th percentile and above
|
200%
|
In addition to evaluating our relative TSR, if the Companys absolute TSR for the performance cycle is zero or less, the Committee will cap the TSR performance factor at target or less. This approach would limit rewards for a performance cycle in which we performed in line with, or better than, the Peer Group, but shareholders did not realize a positive return.
Adjusted Currency-Neutral OCI Growth Performance Factor. The adjusted OCI growth performance factor for the 2017-2019 performance cycle, which determines 30% of the PSU performance factor, will be the compound annual growth rate of the Companys adjusted OCI (excluding currency and acquisitions) as shown below, with linear interpolation for results between the percentages shown:
Three-Year Adjusted OCI CAGR (excluding currency and acquisitions)
| ||||
Result
|
Performance Factor
| |||
Below Threshold
|
<4%
|
0%
| ||
Threshold
|
4%
|
50%
| ||
Target
|
8%
|
100%
| ||
Maximum
|
11%
|
200%
|
The 8% growth that equates to a performance factor of 100% is the upper-end of our mid-term adjusted currency-neutral OCI growth target of 6% to 8%.
Transformation Performance Factor. The Board, the Committee and management consider the success of the Companys RRPs to be vital to the Companys long-term success. Accordingly, the Committee has established specific RRP volume targets that will account for 20% of the PSU performance factor over the 2017-2019 cycle. The Committee established the targets at what it believes are appropriately ambitious levels that reflect the Board-approved three-year plan.
PSU Vesting Mechanics. At the end of the three-year performance cycle, the Companys performance factor for each of the three metrics will be calculated and then weighted, resulting in an overall PSU performance factor from 0-200%. This percentage will be applied to the executives target PSU award to determine the number of shares of common stock to be issued to the executive.
The Committee may adjust the PSU performance metrics if appropriate to reflect significant unplanned acquisitions or dispositions.
40 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
2016 Individual Performance and Compensation Decisions
PMI 2017 Proxy Statement 41
COMPENSATION DISCUSSION AND ANALYSIS |
42 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
Additional Compensation Policies and Processes
Peer Group: The Committee uses a single customized peer group both to benchmark its compensation programs and to compare its TSR when calculating the Companys PSU performance factor. The following 20 companies, selected in 2015 on the basis of their global presence, focus on consumer products, and similarity to the Company in terms of net revenues and market capitalization, constitute our Peer Group:
PMI 2017 Proxy Statement 43
COMPENSATION DISCUSSION AND ANALYSIS |
44 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
PMI 2017 Proxy Statement 45
COMPENSATION DISCUSSION AND ANALYSIS |
46 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
The following table sets forth information concerning the cash and non-cash compensation awarded by PMI to our named executive officers: the Chief Executive Officer, Chief Financial Officer and the three most highly compensated officers serving as executive officers on December 31, 2016. These amounts are based on the compensation earned by these officers while employed by PMI for each year.
Name and Principal Position | Year | Salary (1) ($) |
Stock Awards (2) ($) |
Non-Equity Incentive Plan Compensation (3) ($) |
Change in Pension Value (4) ($) |
All Other Compensation (5) ($) |
Total Compensation ($) | ||||||||||||||||||||||||||||
André Calantzopoulos, Chief Executive Officer |
2016 | 1,501,552 | 11,092,956 | 3,507,393 | 1,839,863 | 182,561 | 18,124,325 | ||||||||||||||||||||||||||||
2015 | 1,538,848 | 8,140,289 | 4,640,861 | 1,828,411 | 180,570 | 16,328,979 | |||||||||||||||||||||||||||||
2014 | 1,615,871 | 7,373,771 | 2,961,504 | 1,941,518 | 232,205 | 14,124,869 | |||||||||||||||||||||||||||||
Marc Firestone, Senior Vice President and General Counsel |
2016 | 1,015,680 | 3,157,371 | 1,552,548 | 662,383 | 19,238 | 6,407,220 | ||||||||||||||||||||||||||||
2015 | 1,039,253 | 3,033,480 | 1,801,209 | 539,493 | 18,168 | 6,431,603 | |||||||||||||||||||||||||||||
2014 | 1,092,660 | 3,381,815 | 1,313,626 | 621,372 | 14,473 | 6,423,946 | |||||||||||||||||||||||||||||
Martin King, President, Asia Region |
2016 | 842,239 | 1,507,449 | 1,024,674 | 1,676,224 | 1,043,628 | 6,094,214 | ||||||||||||||||||||||||||||
2015 | 860,274 | 1,395,384 | 1,080,723 | 978,367 | 1,451,476 | 5,766,224 | |||||||||||||||||||||||||||||
2014 | 904,627 | 1,663,315 | 866,985 | 1,679,182 | 512,818 | 5,626,927 | |||||||||||||||||||||||||||||
Jacek Olczak, Chief Financial Officer |
2016 | 971,563 | 3,286,679 | 1,545,518 | 1,295,084 | 20,746 | 7,119,590 | ||||||||||||||||||||||||||||
2015 | 994,271 | 2,652,546 | 1,796,453 | 1,113,850 | 15,972 | 6,573,092 | |||||||||||||||||||||||||||||
2014 | 1,045,532 | 2,971,427 | 1,196,229 | 1,808,118 | 13,779 | 7,035,085 | |||||||||||||||||||||||||||||
Miroslaw Zielinski, President, Reduced-Risk Products |
2016 | 943,738 | 2,112,721 | 1,298,724 | 1,156,579 | 14,960 | 5,526,722 | ||||||||||||||||||||||||||||
2015 | 964,144 | 1,785,368 | 1,514,641 | 1,057,675 | 44,805 | 5,366,633 | |||||||||||||||||||||||||||||
2014 | 1,013,852 | 1,885,609 | 1,060,438 | 1,469,430 | 45,881 | 5,475,210 |
(1) | The 2016 base salaries are converted to U.S. dollars using an average conversion rate for 2016 of $1.00 = 0.9852 CHF. Year-to-year variations in the salaries and other amounts reported for our officers result in part from year-to-year variations in exchange rates. |
(2) | The amounts shown in this column represent the aggregate grant date fair value of stock awards computed in accordance with FASB ASC Topic 718. The number of shares awarded in 2016, together with the grant date values of each award, is disclosed in the Grants of Plan-Based Awards During 2016 table on page 49. |
The assumptions used in the calculation of the grant date fair value of PSUs awarded in 2016 are described in Note 9 to the consolidated financial statements contained in our 2016 Form 10-K. The table below provides the grant date fair value of PSUs awarded in 2016 for each of our NEOs assuming the maximum level performance is achieved.
Name | 2016 PSUs Maximum ($) | ||||
André Calantzopoulos
|
|
13,754,410
|
| ||
Marc Firestone
|
|
3,914,896
|
| ||
Martin King
|
|
1,868,384
|
| ||
Jacek Olczak
|
|
4,075,596
|
| ||
Miroslaw Zielinski
|
|
2,619,610
|
|
(3) | The 2016 annual incentive compensation awards are converted to U.S. dollars using the conversion rate on December 30, 2016, of $1.00 = 1.0185 CHF. |
(4) | The amounts shown reflect the change in the present value of benefits under the pension plans listed in the Pension Benefits table. The increases in change in present pension value in 2016 were driven by the mandated use of lower interest rates to discount projected future benefits. Such increases would reverse in the event higher interest rates are used in future periods. |
(5) | Details of All Other Compensation for each of the named executive officers appear on the following page. |
PMI 2017 Proxy Statement 47
COMPENSATION DISCUSSION AND ANALYSIS |
Name and Principal Position | Year | International Assignments (a) ($) |
Personal Use of Company Aircraft (b) ($) |
Car Expenses (c) ($) |
Tax Preparation Services (d) ($) |
Totals ($) | ||||||||||||||||||||||||
André Calantzopoulos, Chief Executive Officer |
2016 | - | 149,114 | 31,924 | 1,523 | 182,561 | ||||||||||||||||||||||||
2015 | - | 142,174 | 36,838 | 1,558 | 180,570 | |||||||||||||||||||||||||
2014 | - | 197,002 | 33,565 | 1,638 | 232,205 | |||||||||||||||||||||||||
Marc Firestone, Senior Vice President and General Counsel |
2016 | - | - | 8,722 | 10,516 | 19,238 | ||||||||||||||||||||||||
2015 | - | - | 268 | 17,900 | 18,168 | |||||||||||||||||||||||||
2014 | - | - | - | 14,473 | 14,473 | |||||||||||||||||||||||||
Martin King, President, Asia Region |
2016 | 1,013,498 | - | 30,130 | - | 1,043,628 | ||||||||||||||||||||||||
2015 | 1,438,395 | - | 13,081 | - | 1,451,476 | |||||||||||||||||||||||||
2014 | 495,060 | - | 6,289 | 11,469 | 512,818 | |||||||||||||||||||||||||
Jacek Olczak, Chief Financial Officer |
2016 | - | - | 20,746 | - | 20,746 | ||||||||||||||||||||||||
2015 | - | - | 15,972 | - | 15,972 | |||||||||||||||||||||||||
2014 | - | - | 13,114 | 665 | 13,779 | |||||||||||||||||||||||||
Miroslaw Zielinski, President, Reduced-Risk Products |
2016 | - | - | 11,407 | 3,553 | 14,960 | ||||||||||||||||||||||||
2015 | - | - | 33,935 | 10,870 | 44,805 | |||||||||||||||||||||||||
2014 | - | - | 28,637 | 17,244 | 45,881 |
(a) | The amounts shown include payments or reimbursements made pursuant to PMIs Long-Term Assignment Guidelines, which are designed to facilitate the relocation of employees to positions in other countries by covering expenses over and above those that the employees would have incurred had they remained in their home countries. International assignments and relocations provide a key means for the Company to meet its global employee development and resource needs, and the Long-Term Assignment Guidelines ensure that employees have the necessary financial support to help meet cost differences associated with these assignments. The Long-Term Assignment Guidelines cover housing, home leave, relocation, education expenses and tax equalization, as well as other program allowances. Currently, there are approximately 990 participants in the program. |
(b) | For reasons of security and personal safety, PMI requires Mr. Calantzopoulos to use Company aircraft for all travel. The amounts shown are the incremental cost of personal use of Company aircraft to PMI and include the cost of trip-related crew hotels and meals, in-flight food and beverages, landing and ground handling fees, hourly maintenance contract costs, hangar or aircraft parking costs, fuel costs based on the average annual cost of fuel per hour flown, and other smaller variable costs. Fixed costs that would be incurred in any event to operate Company aircraft (e.g., aircraft purchase costs, depreciation, maintenance not related to personal trips, and flight crew salaries) are not included. Mr. Calantzopoulos has agreed to reimburse the Company for his personal usage of Company aircraft to the extent that the aggregate incremental cost of such usage exceeds $200,000 per fiscal year; he is responsible for his own taxes on any imputed taxable income resulting from personal use of Company aircraft. |
(c) | Amounts shown for Mr. Calantzopoulos include the incremental cost of personal use of driver services that PMI provided for reasons of security and personal safety. With respect to Messrs. Calantzopoulos, Firestone, King, Olczak, and Zielinski, amounts include the cost, amortized over a five-year period, of a vehicle, including insurance, maintenance, repairs and taxes. Executives are responsible for their own taxes on any imputed taxable income resulting from car expenses. |
(d) | The tax preparation services are pursuant to PMI policies that apply to all Swiss payroll-based management employees. |
The following are the specific amounts paid by the Company under the Long-Term Assignment Guidelines:
Name and Principal Position | Year | Housing ($) |
Home Leave ($) |
Relocation ($) |
Tax Equalization (a) ($) |
Other Program Allowances (b) ($) |
Totals ($) | ||||||||||||||||||||||||||||
Martin King, President, Asia Region |
2016 | 415,335 | 20,781 | - | 506,000 | 71,382 | 1,013,498 | ||||||||||||||||||||||||||||
2015 | 259,236 | 27,174 | 136,878 | 943,606 | 71,501 | 1,438,395 | |||||||||||||||||||||||||||||
2014 | 130,463 | 34,328 | 127,616 | 158,210 | 44,443 | 495,060 |
Amounts that were paid or incurred in currency other than U.S. dollars are converted to U.S. dollars using average conversion rates for 2016 of $1.00 = 0.9852 CHF and $1.00 = 7.7621 HKD. |
(a) | The tax equalization payments made pursuant to PMIs Long-Term Assignment Guidelines are to ensure that an assignees income tax liability is approximately the same as if he or she had not accepted a long-term international assignment. Payments for tax equalization often occur in years following the actual tax year. The Company has covered the excess taxes on behalf of Mr. King pursuant to our assignment tax principle. The amount reflected in the table includes the incremental taxes paid by early 2017 in relation to Mr. Kings 2015 and 2016 compensation. |
(b) | Other Program Allowances include tax preparation services paid by the Company under the Long-Term Assignment Guidelines. |
48 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
Grants of Plan-Based Awards During 2016
Estimated Possible Payouts Under Non-Equity Annual Incentive Plan (1) |
Estimated Future Payouts
Under Equity Incentive Plan (2) |
|||||||||||||||||||||||||||||||
Name and Principal Position | Grant Date |
Threshold ($) |
Target ($) |
Maximum ($) |
Threshold (#) |
Target (#) |
Maximum (#) |
All Other Stock Awards: Number of Shares of Stock or Units (3) (#) |
Grant Date Fair Value of Stock Awards ($) |
|||||||||||||||||||||||
André Calantzopoulos, Chief Executive Officer |
|
2016 |
|
0 |
|
2,898,675 |
|
|
6,522,019 |
|
||||||||||||||||||||||
|
2/4/2016
|
|
|
35,520 |
|
|
71,040 |
|
|
142,080 |
|
|
6,877,205 |
| ||||||||||||||||||
|
2/4/2016
|
|
47,360
|
|
4,215,751
|
| ||||||||||||||||||||||||||
Marc Firestone, Senior Vice President and General Counsel |
|
2016 |
|
0 |
1,227,310 | 2,761,448 | ||||||||||||||||||||||||||
|
2/4/2016 |
|
|
10,110 |
|
|
20,220 |
|
|
40,440 |
|
|
1,957,448 |
| ||||||||||||||||||
|
2/4/2016
|
|
13,480
|
|
1,199,923
|
| ||||||||||||||||||||||||||
Martin King, President, Asia Region |
|
2016 |
|
0 |
|
810,021 |
|
|
1,822,547 |
|
||||||||||||||||||||||
|
2/4/2016 |
|
|
4,825 |
|
|
9,650 |
|
|
19,300 |
|
|
934,192 |
| ||||||||||||||||||
|
2/4/2016
|
|
6,440
|
|
573,257
|
| ||||||||||||||||||||||||||
Jacek Olczak, Chief Financial Officer |
|
2016 |
|
0 | 1,170,846 | 2,634,404 | ||||||||||||||||||||||||||
|
2/4/2016 |
|
|
10,525 |
|
|
21,050 |
|
|
42,100 |
|
|
2,037,798 |
| ||||||||||||||||||
|
2/4/2016
|
|
14,030
|
|
1,248,881
|
| ||||||||||||||||||||||||||
Miroslaw Zielinski, President, Reduced-Risk Products |
|
2016 |
|
0 | 908,200 | 2,043,450 | ||||||||||||||||||||||||||
|
2/4/2016 |
|
|
6,765 |
|
|
13,530 |
|
|
27,060 |
|
|
1,309,805 |
| ||||||||||||||||||
|
2/4/2016
|
|
9,020
|
|
802,916
|
|
(1) | The estimated possible payouts are converted to U.S. dollars using the conversion rate on December 30, 2016, of $1.00 = 1.0185 CHF. The numbers in these columns represent the range of potential cash awards as of the time of the grant. Actual awards paid under these plans for 2016 are found in the Non-Equity Incentive Plan Compensation column of the Summary Compensation Table. |
(2) | On February 4, 2016, each of our named executive officers received 60% of his targeted equity award in the form of PSUs. The target number of PSUs awarded was based on the grant date fair market value, determined by using the average of the high and the low trading prices of PMI stock on that date of $89.015. The closing price of PMI stock on that date was $89.10. These equity awards are scheduled to vest on February 20, 2019, to the extent performance goals pre-established and pre-weighted by the Committee are achieved. For the 2016-2018 performance cycle the performance goals are based on TSR, compound annual adjusted OCI growth rate and innovation measures. Dividend equivalents will be payable at vesting only on the earned shares. |
The numbers in these columns represent the potential number of PSUs that can vest at three different levels of performance. Threshold assumes achievement of a threshold performance level for each of the three pre-established performance goals resulting in the vesting of 50% of the target number of PSUs. The vesting percentage can be 0 if none of the threshold levels is achieved. |
(3) | On February 4, 2016, each of our named executive officers received 40% of his targeted equity award in the form of RSUs. The number of RSUs awarded was based on the grant date fair market value, determined by using the average of the high and the low trading prices of PMI stock on that date of $89.015. The closing price of PMI stock on that date was $89.10. These equity awards are scheduled to vest on February 20, 2019. Dividend equivalents are payable on a quarterly basis throughout the vesting restriction period. |
On February 2, 2017, the following named executive officers received equity awards that are scheduled to vest (subject to the conditions of the awards) on February 19, 2020, as follows: Mr. Calantzopoulos, 41,870 RSUs, 62,800 PSUs; Mr. Firestone, 13,000 RSUs, 19,500 PSUs; Mr. King, 6,830 RSUs, 10,240 PSUs; Mr. Olczak, 12,940 RSUs, 19,410 PSUs; and Mr. Zielinski, 8,650 RSUs, 12,980 PSUs. The amount of these awards was determined based on 2016 individual performance and targeted award levels by salary grade and then split between RSUs (40%) and PSUs (60%). |
PMI 2017 Proxy Statement 49
COMPENSATION DISCUSSION AND ANALYSIS |
Outstanding Equity Awards as of December 31, 2016
Stock Awards | |||||||||||||||||||||||||
RSUs | PSUs | ||||||||||||||||||||||||
Name and Principal Position | Stock Award Grant Date (1) |
Number of Units that Have not (#) |
Market Value Have not Vested (3) ($) |
Number of Units that Have not (#) |
Market or Have not Vested (3) ($) | ||||||||||||||||||||
André Calantzopoulos, Chief Executive Officer |
2/4/2016 | 71,040 | 6,499,450 | ||||||||||||||||||||||
2/4/2016 | 47,360 | 4,332,966 | |||||||||||||||||||||||
2/5/2015 | 98,940 | 9,052,021 | |||||||||||||||||||||||
|
2/6/2014
|
|
|
94,870
|
|
|
8,679,656
|
|
|||||||||||||||||
Marc Firestone, Senior Vice President and General Counsel |
2/4/2016 | 20,220 | 1,849,928 | ||||||||||||||||||||||
2/4/2016 | 13,480 | 1,233,285 | |||||||||||||||||||||||
2/5/2015 | 36,870 | 3,373,236 | |||||||||||||||||||||||
|
2/6/2014
|
|
|
43,510
|
|
|
3,980,730
|
|
|||||||||||||||||
Martin King, President, Asia Region |
2/4/2016 | 9,650 | 882,879 | ||||||||||||||||||||||
2/4/2016 | 6,440 | 589,196 | |||||||||||||||||||||||
2/5/2015 | 16,960 | 1,551,670 | |||||||||||||||||||||||
|
2/6/2014
|
|
|
21,400
|
|
|
1,957,886
|
|
|||||||||||||||||
Jacek Olczak, Chief Financial Officer |
2/4/2016 | 21,050 | 1,925,865 | ||||||||||||||||||||||
2/4/2016 | 14,030 | 1,283,605 | |||||||||||||||||||||||
2/5/2015 | 32,240 | 2,949,638 | |||||||||||||||||||||||
|
2/6/2014
|
|
|
38,230
|
|
|
3,497,663
|
|
|||||||||||||||||
Miroslaw Zielinski, President, Reduced-Risk Products |
2/4/2016 | 13,530 | 1,237,860 | ||||||||||||||||||||||
2/4/2016 | 9,020 | 825,240 | |||||||||||||||||||||||
2/5/2015 | 21,700 | 1,985,333 | |||||||||||||||||||||||
|
2/6/2014
|
|
|
24,260
|
|
|
2,219,547
|
|
(1) | These awards vest according to the following schedule: |
Grant Date |
Grant Type |
Vesting Schedule |
||||
2/4/2016 | PSU | Award vests between 0-200% on 2/20/2019 upon certification of the achievement of performance goals pre-established by the Committee.
|
||||
2/4/2016
|
RSU
|
100% of award vests on 2/20/2019.
|
||||
2/5/2015
|
RSU
|
100% of award vests on 2/21/2018.
|
||||
2/6/2014
|
RSU
|
100% of award vests on 2/15/2017.
|
Upon normal retirement or upon separation from employment by mutual agreement after reaching age 58, outstanding RSUs will vest immediately, while outstanding PSUs will vest at the end of the relevant three-year performance cycle to the extent performance goals are met. Upon death or disability, all outstanding RSUs will vest and all outstanding PSUs will vest at 100% of target. In all other cases, the extent of vesting or forfeiture will be subject to the Committees discretion. |
(2) | Dividend equivalents paid in 2016 on outstanding RSUs for each of our named executive officers were as follows: Mr. Calantzopoulos, $1,004,279; Mr. Firestone, $415,780; Mr. King, $199,713; Mr. Olczak, $370,965; and Mr. Zielinski, $245,737. |
(3) | Based on the closing market price of PMI common stock on December 30, 2016, of $91.49. |
(4) | Amount assumes target performance goals are achieved. The actual number of units that vest will range between 0% and 200% depending on actual performance during the performance cycle. |
50 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
Stock Option Exercises (1) and Stock Vested During 2016
Stock Awards
|
||||||
Name and Principal Position | Number of Shares Acquired on Vesting (#) |
Value Realized on Vesting ($) |
||||
André Calantzopoulos, Chief Executive Officer
|
74,260 | 6,755,804 | ||||
Marc Firestone, Senior Vice President and General Counsel
|
48,270 | 4,391,363 | ||||
Martin King, President, Asia Region
|
24,270 | 2,207,963 | ||||
Jacek Olczak, Chief Financial Officer
|
42,080 | 3,828,228 | ||||
Miroslaw Zielinski, President, Reduced-Risk Products
|
31,530 | 2,868,442 |
(1) | The Company does not issue stock options. |
On February 15, 2017, vesting restrictions lapsed for the following RSUs granted in 2014: Mr. Calantzopoulos, 94,870 shares; Mr. Firestone, 43,510 shares; Mr. King, 21,400 shares; Mr. Olczak, 38,230 shares; and Mr. Zielinski, 24,260 shares.
PMI 2017 Proxy Statement 51
COMPENSATION DISCUSSION AND ANALYSIS |
The Pension Benefits table and the Non-Qualified Deferred Compensation table below generally reflect amounts accumulated as a result of the named executive officers service over their full careers with us, our prior parent company and affiliates. The increments related to 2016 are reflected in the Change in Pension Value column of the Summary Compensation Table on page 47. Our plans providing pension benefits are described below in the Pension Benefits table, and our defined contribution plans are described in the Non-Qualified Deferred Compensation table on page 56.
Name and Principal Position | Plan Name | Number of (#) |
Present Value ($) |
Payments During Last Fiscal Year ($) | ||||
André Calantzopoulos, Chief Executive Officer |
Pension Fund of Philip Morris in Switzerland |
35.00 | 16,330,826 | - | ||||
IC Pension Plan of Philip Morris in Switzerland | 11.92 | 2,434,361 | - | |||||
Supplemental Plan of Philip Morris in Switzerland
|
11.00
|
6,568,028
|
-
| |||||
Marc Firestone, Senior Vice President and General Counsel
|
Pension Fund of Philip Morris in Switzerland | 4.75 | 1,749,139 | - | ||||
IC Pension Plan of Philip Morris in Switzerland | 3.92 | 149,863 | - | |||||
Supplemental Plan of Philip Morris in Switzerland
|
4.75
|
708,985
|
-
| |||||
Martin King, President, Asia Region |
Pension Fund of Philip Morris in Switzerland | 11.58 | 3,532,845 | - | ||||
IC Pension Plan of Philip Morris in Switzerland | 10.92 | 588,846 | - | |||||
Supplemental Plan of Philip Morris in Switzerland | 8.00 | 942,792 | - | |||||
Retirement Plan for Salaried Employees | 14.00 | 788,453 | - | |||||
Benefit Equalization Plan (BEP)
|
14.00
|
3,942,898
|
-
| |||||
Jacek Olczak, Chief Financial Officer |
Pension Fund of Philip Morris in Switzerland | 27.00 | 9,210,078 | - | ||||
IC Pension Plan of Philip Morris in Switzerland | 10.92 | 587,751 | - | |||||
Supplemental Plan of Philip Morris in Switzerland
|
8.00
|
1,908,360
|
-
| |||||
Miroslaw Zielinski, President, Reduced- Risk Products
|
Pension Fund of Philip Morris in Switzerland | 31.00 | 10,148,615 | - | ||||
IC Pension Plan of Philip Morris in Switzerland | 11.92 | 1,050,376 | - | |||||
Supplemental Plan of Philip Morris in Switzerland
|
11.00
|
1,818,887
|
-
|
(1) | As of December 31, 2016, each named executive officers total years of service with PMI or its affiliates were as follows: Mr. Calantzopoulos, 31.92 years; Mr. Firestone, 4.71 years; Mr. King, 25.58 years; Mr. Olczak, 23.79 years; and Mr. Zielinski, 25.33 years; the years shown in this column are the years credited under the named plan for purposes of benefit accrual. Additional years may count for purposes of vesting or early retirement eligibility. Differences between each named executive officers total service and the credited service shown for each plan result from transfers between entities sponsoring various plans. Mr. Kings credited service under the U.S. plans reflects his prior service as a U.S. payroll-based employee. While such credited service is now frozen, he continues to earn eligibility and vesting service and increases in his benefit due to increases in his compensation as a result of his continued service with PMI. The Pension Fund of Philip Morris in Switzerland allows employees to purchase additional service credit with contributions from their own funds, and Messrs. Calantzopoulos, Olczak, and Zielinski have purchased 3.08, 15.67, and 13.83 years, respectively, without any Company contribution. |
(2) | The amounts shown in this column for pension plans in Switzerland are based on a 60% joint and survivor annuity commencing at age 62 (the earliest date on which, assuming continued employment, the individual would be eligible for benefits that are not reduced for early commencement) and the following actuarial assumptions: discount rate 0.59%, mortality table LPP 2015 with a load of 2.00% for expected improvements in mortality and interest rate on account balances of 3.4%. Present value amounts in Swiss francs are converted to U.S. dollars using the conversion rate on December 30, 2016, of $1.00 = 1.0185 CHF. |
The amounts shown in this column for Mr. Kings U.S. pension benefits are based on a single life annuity (or, for the BEP, a lump sum payment) using the same assumptions applied for year-end 2016 financial disclosure under FASB ASC Topic 715, except that in accordance with SEC requirements, benefits are assumed to commence at the earliest date on which, assuming continued employment, the individual would be eligible for benefits that are not reduced for early commencement. |
See Note 13 to our consolidated financial statements for a description of our FASB ASC Topic 715 assumptions. Like all present value amounts, the amounts shown in this column change as the interest rate used to discount projected future benefits is adjusted, with lower interest rates producing higher present values and higher interest rates producing lower present values. |
52 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
(3) | In addition to the benefits reflected in this column, we generally provide a survivor income benefit allowance, or SIB allowance, to the surviving spouse and children of U.S. payroll-based employees who die while covered by our Retirement Plan for Salaried Employees. Following the death of a retiree who has a spouse and whose retirement benefits are being paid as a single life annuity, the surviving spouse becomes entitled to a SIB allowance four years after the retirees death, in an amount equal to the amount the spouse would have received if the participant had elected to receive monthly payments under the Retirement Plan in the form of a 50% joint and survivor annuity. The surviving spouse of a participant who dies prior to retirement and prior to age 61 becomes entitled to receive 25% of the base salary of the deceased employee commencing four years after the participants death, provided the spouse has not remarried, and continuing until the deceased employee would have reached age 65. At that time, the surviving spouse receives the same survivor benefit he or she would have received if the deceased employee continued to work until age 65 earning the same base salary as in effect at the time of death. These benefits are reduced by any death benefits payable from the Retirement Plan. If there is no surviving spouse, SIB allowances for each child equal 10% of the base salary of the deceased employee (to a maximum of 30% of base salary), become payable monthly beginning four years after the employees death, and continue until the child reaches age 25 if a full-time student (age 19 if not). The present value of such post-retirement SIB benefits for Mr. King, assuming his spouse survives him, is $40,842. There is no SIB allowance under the BEP since the BEP benefit is only available as a lump sum. |
PMI 2017 Proxy Statement 53
COMPENSATION DISCUSSION AND ANALYSIS |
54 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
PMI 2017 Proxy Statement 55
COMPENSATION DISCUSSION AND ANALYSIS |
Non-Qualified Deferred Compensation
Name and Principal Position | Plan Name | Executive ($) |
Registrant ($) |
Aggregate ($) |
Aggregate ($) |
Aggregate ($) | |||||||||||||||||||||
Martin King, President, Asia Region
|
Benefit Equalization Plan (BEP), Deferred Profit-Sharing
|
0 | 0 | 306 | 0 | 19,900 |
(1) | The amount in this column consists of amounts credited as earnings for 2016 on account balances attributable to the prior participation under the defined contribution portion of the BEP. This amount does not constitute above-market earnings and, accordingly, is not included in amounts reported in the Summary Compensation Table on page 47. |
Deferred Profit-Sharing and Benefit Equalization Plan
56 PMI 2017 Proxy Statement
COMPENSATION DISCUSSION AND ANALYSIS |
Employment Contracts, Termination of Employment and Change in Control Arrangements
PMI 2017 Proxy Statement 57
ADVISORY VOTE APPROVING EXECUTIVE COMPENSATION |
The Board recommends a vote FOR the resolution approving the compensation of
our named executive officers.
58 PMI 2017 Proxy Statement
ADVISORY VOTE ON THE FREQUENCY OF FUTURE SAY-ON-PAY VOTES |
The Board recommends a vote of once EVERY YEAR as the frequency with which shareholders are provided an advisory vote on executive compensation.
PMI 2017 Proxy Statement 59
APPROVAL OF THE 2017 PERFORMANCE INCENTIVE PLAN |
The Board of Directors has adopted the 2017 Performance Incentive Plan (the 2017 Plan) to replace the 2012 Performance Incentive Plan, which was approved by our shareholders in 2012 (the 2012 Plan). The 2017 Plan, like the 2012 Plan, permits the Company to compensate management with equity and cash incentive awards. New awards will not be made under the 2017 Plan until shareholder approval is obtained for the Plan. The Company has no plans to grant additional awards under the 2012 Plan after the date of this proxy statement.
The 2017 Plan provides the Compensation and Leadership Development Committee with the flexibility to compensate executives through various awards. These awards may be tied to the financial or operational performance of the Company as well as to the performance of the Companys stock. Because of the key role the 2017 Plan will play in the compensation of executives, the Board urges you to vote for its approval.
The terms of the 2017 Plan are summarized below. In addition, the full text of the 2017 Plan is set forth in Exhibit B to this Proxy Statement. The following summary is qualified in its entirety by reference to the text of the 2017 Plan. Shareholder approval of the 2017 Plan is one of the requirements for allowing us to continue to make certain awards to executive officers that will be tax-deductible by us as performance-based compensation for U.S. tax purposes.
Comparison of the 2017 Plan and the 2012 Plan
The following compares the key provisions of the two plans:
▪ | the term of each of the Plans is five years; |
▪ | the 2012 Plan authorized 30 million shares of common stock, while the 2017 Plan authorizes 25 million shares, representing 1.61% of shares outstanding as of March 10, 2017; |
▪ | both Plans prohibit the recycling of shares available for issuance with shares that are forfeited or withheld to pay taxes; |
▪ | each of the Plans authorizes restricted shares, restricted share units, performance-based cash incentive awards and performance-based equity awards; |
▪ | neither Plan authorizes stock options or stock appreciation rights; |
▪ | each Plan features a double-trigger change in control provision as further described on pages 57 and 62; |
▪ | the Board has adopted a clawback policy applicable to each Plan providing for the recovery of incentive compensation in appropriate circumstances as described on page 44, and the 2017 Plan requires that all awards thereunder are subject to this policy; and |
▪ | the Board has adopted rigorous stock ownership requirements and anti-hedging and anti-pledging policies for executives intended to align their interests with those of our shareholders and to protect against inappropriate risk taking as described on page 44. |
60 PMI 2017 Proxy Statement
APPROVAL OF THE 2017 PERFORMANCE INCENTIVE PLAN |
Run Rates and Dilution. The following table sets forth information regarding equity awards granted, the run rate for each of the last three fiscal years and the average run rate over the last three years. The Companys regular annual long-term equity awards are granted in February of each year. The last column reflects awards issued through March 10, 2017.
RUN RATE (shares in millions) | FY 2014 | FY 2015 | FY 2016 | 3-Year Average |
YTD 2017 |
|||||||||||||||
RSUs granted
|
|
2.43
|
|
|
1.54
|
|
|
1.21
|
|
|
1.73
|
|
|
1.20
|
| |||||
Director Stock Awards granted
|
|
0.02
|
|
|
0.03
|
|
|
0.03
|
|
|
0.03
|
|
|
-
|
| |||||
PSUs vested
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
|
|
-
|
| |||||
Weighted average number of shares outstanding
|
|
1,566.37
|
|
|
1,548.90
|
|
|
1,551.06
|
|
|
1,555.44
|
|
|
1,552.00
|
| |||||
Run rate (1)
|
|
0.16
|
%
|
|
0.10
|
%
|
|
0.08
|
%
|
|
0.11
|
%
|
|
0.08
|
%
|
(1) | Run rate includes the sum of all director stock awards and RSUs granted during the period, plus the number of all PSUs vested during the period, divided by the weighted average number of shares outstanding during the period. The Company does not issue stock options. |
The Companys run rates as shown above and its 2016 year-end overhang (number of unvested RSUs plus unvested PSUs (at target) as a percentage of all shares outstanding at year-end) of 0.32% each compares favorably to those of its Peer Group.
Eligibility. Employees of the Company, its subsidiaries and its affiliates, who are responsible for or contribute to the management, growth and profitability of the Company, its subsidiaries and affiliates, are eligible to receive awards under the 2017 Plan. Such eligible employees include executive officers, senior officers, and other key executive and management employees (currently, approximately 8,750). Awards that are paid to our named executive officers (other than the Chief Financial Officer) are potentially subject to the tax deduction limitations of Section 162(m) of the Internal Revenue Code (the Code). The limitations of Section 162(m) do not apply, however, to performance-based compensation that meets certain requirements, including shareholder approval of the plan.
Business Criteria for Performance Goals. The performance goals for awards that are intended to constitute performance-based compensation for purposes of Section 162(m) will be based on one or more of the following criteria: earnings per share; total shareholder return; net revenues; operating income; operating companies income; net income; earnings before interest, taxes, depreciation and amortization expenses; free cash flow; operating cash flow; return on equity; return on capital; economic value added; product volume or market share; product innovation; changes in the overall cost base; operating margin; attainment of product commercialization targets; achievement of research and development milestones and other strategic initiatives; achievement of regulatory milestones; portfolio transformation; or achievement of diversity and inclusion goals. The measures of these criteria may be adjusted in a manner consistent with the practices of the Company in communicating results.
Negative Discretion. Notwithstanding the achievement of any performance goal established under the 2017 Plan, the Committee has the discretion to reduce some or all of a performance-based award that would otherwise be paid to a participant.
Incentive Awards. Incentive awards expressed in cash, common stock, or both may be granted under the 2017 Plan. These awards will be earned only if corporate, business unit or individual performance objectives over performance cycles established by or under the direction of the Committee, are met.
Restricted Shares and Restricted Share Units. Restricted shares and RSUs may also be awarded. Restricted shares are shares of common stock issued to a recipient while RSUs represent the right to receive shares, in each case that vest and become transferable upon the satisfaction of conditions described in the applicable award agreement. Restricted shares and RSUs may be forfeited if, for example, the recipients employment terminates before the award vests. Except as specified in the applicable award agreement, the holder of a restricted share award will have all the rights of a holder of common stock on his or her restricted shares, including the right to receive dividends. The holder of RSUs will have none of the rights of a holder of common stock unless and until shares of common stock are actually delivered in satisfaction of such units. The Committee may provide for the payment of dividend equivalents with respect to any shares of common stock subject to unvested RSUs.
Performance Share Units. PSUs are performance-based awards denominated in shares of common stock and based on the achievement of pre-established performance goals during a performance cycle, with the vesting percentage determined
PMI 2017 Proxy Statement 61
APPROVAL OF THE 2017 PERFORMANCE INCENTIVE PLAN |
by formula. The recipient of PSUs will have none of the rights of a holder of common stock until shares are earned and delivered in satisfaction of such units. The Committee may provide for the payment of dividend equivalents with respect to shares that are actually earned at the end of a performance cycle.
U.S. Federal Income Tax Consequences.
Restricted Shares. The recognition of income from an award of restricted shares for federal income tax purposes depends on the restrictions imposed on the shares. Generally, taxation will be deferred until the first taxable year the shares are no longer subject to substantial risk of forfeiture. At the time the restrictions lapse, the employee will recognize ordinary income equal to the then fair market value of the shares. The employee may, however, make an election to include the value of the shares in gross income in the year of award despite such restrictions. Generally, PMI will be entitled to deduct the fair market value of the shares transferred to the employee as a business expense in the year the employee includes the compensation in income.
RSUs and PSUs. Generally, an employee will not recognize ordinary income until the shares become payable, even if the award vests in an earlier year. PMI will generally be entitled to deduct the amount the employee includes in income as a business expense in the year of payment.
Cash Incentive Awards. Any cash payment an employee receives under an incentive award will generally be included in the employees income, as ordinary income, in the year paid. PMI will generally be entitled to deduct the amount the employee includes in income as a business expense in the year of payment.
Deductibility of Awards. Section 162(m) places a $1.0 million annual limit on the compensation deductible by PMI paid to certain of its executives. The limit, however, does not apply to qualified performance-based compensation. PMI believes that cash incentive awards and PSUs under the 2017 Plan will qualify for the performance-based compensation exception to the deductibility limit. The Committee retains the discretion to issue awards that are not so qualified.
Other Tax Consequences. State tax consequences may in some cases differ from those described above. Awards under the 2017 Plan will in many instances be made to employees who are subject to tax in jurisdictions other than the United States and may result in tax consequences differing from those described above.
Award Limits. The 2017 Plan places limits on the maximum amount of each type of award that may be granted to any employee in any plan year. The maximum number of shares of common stock that may be the subject of all awards that are intended to comply with the performance-based exception under Section 162(m) awarded to any employee during any single calendar year shall not exceed 500,000. For awards that are settled in cash but denominated in shares of common stock, the maximum aggregate amount of cash that may be paid to a participant in a single calendar year is equal to 500,000 multiplied by the fair market value of a share of common stock on the payment date. The maximum amount of all awards denominated in cash that are intended to comply with the performance-based exception under Section 162(m) that can be paid to any employee during any single calendar year shall not exceed $10 million for awards with a performance cycle of one year or less and shall not exceed such annual maximum multiplied by the number of years in any performance cycle having a term of more than one year.
Award limits that are expressed as a number of shares will be adjusted appropriately in the event of any transaction or event that affects our common stock, including but not limited to a merger, share exchange, reorganization, consolidation, recapitalization, reclassification, distribution, stock dividend, stock split, reverse stock split, split-up, spin-off or issuance of rights or warrants.
Change in Control. The 2017 Plan includes a double-trigger feature under which outstanding equity awards will not accelerate or vest if the entity acquiring PMI agrees to replace the award with a time-based equity award of equivalent value. For this purpose, the value of outstanding PSUs would be determined based on actual performance through the date of the change in control if more than one-half of the performance cycle has elapsed and such performance is determinable. Otherwise, the value of outstanding PSUs would be based on the assumption that target performance had been achieved.
If outstanding equity awards are not replaced, outstanding RSUs would fully vest and the value of outstanding PSUs would be determined as set forth above and be payable immediately in cash.
If outstanding equity awards are replaced as described above but, within two years after the change in control, the employees employment is terminated involuntarily and other than for cause or the employee terminates employment for
62 PMI 2017 Proxy Statement
APPROVAL OF THE 2017 PERFORMANCE INCENTIVE PLAN |
good reason, the replacement award would fully vest. The definition of change in control in the 2017 Plan is similar to that in the 2012 Plan (summarized on page 57), except that no change in control is deemed to occur in certain business combination transactions if beneficial owners prior to such transaction beneficially own more than 50% in an entity resulting from such transaction (as opposed to 60% in the 2012 Plan).
Future Awards. Future awards under the 2017 Plan cannot be determined at this time because grants are at the discretion of the Committee. However, we believe that incentive and equity awards granted under the 2012 Plan in 2016 would not have been any different had they been awarded under the 2017 Plan.
Shares Remaining Under the Companys Equity Compensation Plans. The number of shares to be issued upon exercise or vesting and the number of shares remaining available for future issuance under the 2012 Plan and the Philip Morris International Inc. 2008 Stock Compensation Plan for Non-Employee Directors at March 10, 2017, were as follows:
(A) Number of Shares to be Issued upon Exercise of Outstanding Options and Vesting of RSUs and PSUs |
(B) Weighted Average Exercise Price of Outstanding Options |
(C) Number of Shares Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column A) | |||||||||||||
Equity compensation plans approved by shareholders (1)
|
|
5,392,560
|
(2)
|
|
-
|
|
|
19,868,589
|
(3)
|
(1) | The 2008 Stock Compensation Plan for Non-Employee Directors was approved by our former parent company in connection with our spin-off. |
(2) | Represents 3,750,500 shares of common stock that may be is |